sample case study stroke patient

• Remote Access
• Save figures into PowerPoint
• Download tables as PDFs

Chapter 7:  10 Real Cases on Transient Ischemic Attack and Stroke: Diagnosis, Management, and Follow-Up

Jeirym Miranda; Fareeha S. Alavi; Muhammad Saad

• Download Chapter PDF

Disclaimer: These citations have been automatically generated based on the information we have and it may not be 100% accurate. Please consult the latest official manual style if you have any questions regarding the format accuracy.

Download citation file:

• Search Book

Jump to a Section

Case review, case discussion, clinical symptoms.

• Radiologic Findings
• Full Chapter
• Supplementary Content

Case 1: Management of Acute Thrombotic Cerebrovascular Accident Post Recombinant Tissue Plasminogen Activator Therapy

A 59-year-old Hispanic man presented with right upper and lower extremity weakness, associated with facial drop and slurred speech starting 2 hours before the presentation. He denied visual disturbance, headache, chest pain, palpitations, dyspnea, dysphagia, fever, dizziness, loss of consciousness, bowel or urinary incontinence, or trauma. His medical history was significant for uncontrolled type 2 diabetes mellitus, hypertension, hyperlipidemia, and benign prostatic hypertrophy. Social history included cigarette smoking (1 pack per day for 20 years) and alcohol intake of 3 to 4 beers daily. Family history was not significant, and he did not remember his medications. In the emergency department, his vital signs were stable. His physical examination was remarkable for right-sided facial droop, dysarthria, and right-sided hemiplegia. The rest of the examination findings were insignificant. His National Institutes of Health Stroke Scale (NIHSS) score was calculated as 7. Initial CT angiogram of head and neck reported no acute intracranial findings. The neurology team was consulted, and intravenous recombinant tissue plasminogen activator (t-PA) was administered along with high-intensity statin therapy. The patient was admitted to the intensive care unit where his hemodynamics were monitored for 24 hours and later transferred to the telemetry unit. MRI of the head revealed an acute 1.7-cm infarct of the left periventricular white matter and posterior left basal ganglia. How would you manage this case?

This case scenario presents a patient with acute ischemic cerebrovascular accident (CVA) requiring intravenous t-PA. Diagnosis was based on clinical neurologic symptoms and an NIHSS score of 7 and was later confirmed by neuroimaging. He had multiple comorbidities, including hypertension, diabetes, dyslipidemia, and smoking history, which put him at a higher risk for developing cardiovascular disease. Because his symptoms started within 4.5 hours of presentation, he was deemed to be a candidate for thrombolytics. The eligibility time line is estimated either by self-report or last witness of baseline status.

Ischemic strokes are caused by an obstruction of a blood vessel, which irrigates the brain mainly secondary to the development of atherosclerotic changes, leading to cerebral thrombosis and embolism. Diagnosis is made based on presenting symptoms and CT/MRI of the head, and the treatment is focused on cerebral reperfusion based on eligibility criteria and timing of presentation.

Symptoms include alteration of sensorium, numbness, decreased motor strength, facial drop, dysarthria, ataxia, visual disturbance, dizziness, and headache.

Get Free Access Through Your Institution

Pop-up div successfully displayed.

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

Please Wait

Want to create or adapt books like this? Learn more about how Pressbooks supports open publishing practices.

This case study presents a 68-year old “right-handed” African-American man named Randall Swanson. He has a history of hypertension, hyperlipidemia and a history of smoking one pack per day for the last 20 years. He is prescribed Atenolol for his HTN, and Simvastatin for Hyperlipidemia (but he has a history of not always taking his meds). His father had a history of hypertension and passed away from cancer 10 years ago. His mother has a history of diabetes and is still alive.

Randall was gardening with his wife on a relaxing Sunday afternoon. Out of nowhere, Randall fell to the ground. When his wife rushed to his side and asked how he was doing, he answered with garbled and incoherent speech. It was then that his wife noticed his face was drooping on the right side. His wife immediately called 911 and paramedics arrived within 6 minutes. Upon initial assessment, the paramedics reported that Randall appeared to be experiencing a stroke as he presented with right-sided facial droop and weakness and numbness on the right side of his body. Fortunately, Randall lived nearby a stroke center so he was transported to St. John’s Regional Medical Center within 17 minutes of paramedics arriving to his home.

Initial Managment

Upon arrival to the Emergency Department, the healthcare team was ready to work together to diagnose Randall. He was placed in bed with the HOB elevated to 30 degrees to decrease intracranial pressure and reduce any risks for aspiration. Randall’s wife remained at his side and provided the care team with his brief medical history which as previously mentioned, consists of hypertension, hyperlipidemia and smoking one pack per day for the last 20 years. He had no recent head trauma, never had a stroke, no prior surgeries, and no use of anticoagulation medications.

Physical Assessment

Upon first impression, Nurse Laura recognized that Randall was calm but looked apprehensive. When asked to state his name and date of birth, his speech sounded garbled at times and was very slow, but he could still be understood. He could not recall the month he was born in but he was alert and oriented to person, time, and situation. When asked to state where he was, he could not recall the word hospital. He simply pointed around the room while repeating “here.”

Further assessment revealed that his pupils were equal and reactive to light and that he presented with right-sided facial paralysis. Randall was able to follow commands but when asked to move his extremities, he could not lift his right arm and leg. He also reported that he could not feel the nurse touch his right arm and leg. Nurse Laura gathered the initial vital signs as follows: BP: 176/82, HR: 93, RR: 20, T:99.4, O2: 92% RA and a headache with pain of 3/10.

Doctor’s Orders

The doctor orders were quickly noted and included:

-2L O2 (to keep O2 >93%)

– 500 mL Bolus NS

– VS Q2h for the first 8 hrs.

-Draw labs for: CBC, INR, PT/INR, PTT, and Troponin

-Get an EKG

-Chest X ray

-Glucose check

-Obtain patient weight

-Perform a National Institute of Health Stroke Scale (also known as NIHSS) Q12h for the first 24 hours, then Q24h until he is discharged

-Notify pharmacy of potential t-PA preparation.

Nursing Actions

Nurse Laura started an 18 gauge IV in Randall’s left AC and started him on a bolus of 500 mL of NS. A blood sample was collected and quickly sent to the lab. Nurse Laura called the Emergency Department Tech to obtain a 12 lead EKG.

Pertinent Lab Results for Randall

The physician and the nurse review the labs:

WBC 7.3 x 10^9/L

RBC 4.6 x 10^12/L

Plt 200 x 10^9/L

LDL 179 mg/dL

HDL 43 mg/dL

Troponin <0.01 ng/mL

EKG and Chest X Ray Results

The EKG results and monitor revealed Randall was in normal sinus rhythm; CXR was negative for pulmonary or cardiac pathology

CT Scan and NIHSS Results 

The NIH Stroke Scale was completed and demonstrated that Randall had significant neurological deficits with a score of 13. Within 20 minutes of arrival to the hospital, Randall had a CT-scan completed. Within 40 minutes of arrival to the hospital, the radiologist notified the ED physician that the CT-scan was negative for any active bleeding, ruling our hemorrhagic stroke.

The doctors consulted and diagnosed Randall with a thrombotic ischemic stroke and determined that that plan would include administering t-PA. Since Randall’s CT scan was negative for a bleed and since he met all of the inclusion criteria he was a candidate for t-PA. ( Some of the inclusion criteria includes that the last time the patient is seen normal must be within 3 hours, the CT scan has to be negative for bleeding, the patient must be 18 years or older, the doctor must make the diagnosis of an acute ischemic stroke, and the patient must continue to present with neurological deficits.)

Since the neurologist has recommended IV t-PA, the physicians went into Randall’s room and discussed what they found with him and his wife. Nurse Laura answered and addressed any remaining concerns or questions.

Administration

Randall and his wife decided to proceed with t-PA therapy as ordered, therefore Nurse Laura initiated the hospital’s t-PA protocol. A bolus of 6.73 mg of tPA was administered for 1 minute followed by an infusion of 60.59 mg over the course of 1 hour. ( This was determined by his weight of 74.8 kg).  After the infusion was complete, Randall was transferred to the ICU for close observation. Upon reassessment of the patient, Randall still appeared to be displaying neurological deficits and his right-sided paralysis had not improved. His vital signs were assessed and noted as follows: BP: 149/79 HR: 90 RR: 18 T:98.9 O2: 97% 2L NC Pain: 2/10.

Randall’s wife was crying and he appeared very scared, so Nurse John tried to provide as much emotional support to them as possible. Nurse John paid close attention to Randall’s blood pressure since he could be at risk for hemorrhaging due to the medication. Randall was also continually assessed for any changes in neurological status and allergic reactions to the t-PA. Nurse John made sure that Stroke Core Measures were followed in order to enhance Randall’s outcome.

In the ICU, Randall’s neurological status improved greatly. Nurse Jan noted that while he still garbled speech and right-sided facial droop, he was now able to recall information such as his birthday and he could identify objects when asked. Randall was able to move his right arm and leg off the bed but he reported that he was still experiencing decreased sensation, right-sided weakness and he demonstrated drift in both extremities.

The nurse monitored Randall’s blood pressure and noted that it was higher than normal at 151/83. She realized this was an expected finding for a patient during a stroke but systolic pressure should be maintained at less than 185 to lower the risk of hemorrhage. His vitals remained stable and his NIHSS score decreased to an 8. Labs were drawn and were WNL with the exception of his LDL and HDL levels. His vital signs were noted as follows: BP 151/80 HR 92 RR 18 T 98.8 O2 97% RA Pain 0/10

The Doctor ordered Physical, Speech, and Occupational therapy, as well as a swallow test.

Swallowing Screen

Randall remained NPO since his arrival due to the risks associated with swallowing after a stroke. Nurse Jan performed a swallow test by giving Randall 3 ounces of water. On the first sip, Randall coughed and subsequently did not pass. Nurse Jan kept him NPO until the speech pathologist arrived to further evaluate Randall. Ultimately, the speech  pathologist determined that with due caution, Randall could be put on a dysphagia diet that featured thickened liquids

Physical Therapy & Occupational Therapy

A physical therapist worked with Randall and helped him to carry out passive range of motion exercises. An occupational therapist also worked with Randall to evaluate how well he could perform tasks such as writing, getting dressed and bathing. It was important for these therapy measures to begin as soon as possible to increase the functional outcomes for Randall. Rehabilitation is an ongoing process that begins in the acute setting.

Day 3- third person 

During Day 3, Randall’s last day in the ICU, Nurse Jessica performed his assessment. His vital signs remained stable and WNL as follows: BP: 135/79 HR: 90 RR: 18 T: 98.9 O2: 97% on RA, and Pain 0/10. His NIHSS dramatically decreased to a 2. Randall began showing signs of improved neurological status; he was able to follow commands appropriately and was alert and oriented x 4. The strength  in his right arm and leg markedly improved. he was able to lift both his right arm and leg well and while he still reported feeling a little weakness and sensory loss, the drift in both extremities was absent.

Rehabilitation Therapies

Physical, speech, and occupational therapists continued to work with Randall. He was able to call for assistance and ambulate with a walker to the bathroom and back. He was able to clean his face with a washcloth, dress with minimal assistance, brush his teeth, and more. Randall continued to talk with slurred speech but he was able to enunciate with effort.

On day 4, Randall was transferred to the med-surg floor to continue progression. He continued to work with physical and occupational therapy and was able to perform most of his ADLs with little assistance. Randall could also ambulate 20 feet down the hall with the use of a walker.

Long-Term Rehabilitation and Ongoing Care

On day 5, Randall was discharged to a rehabilitation facility and continued to display daily improvement. The dysphagia that he previously was experiencing resolved and he was discharged home 1.5 weeks later. Luckily for Randall, his wife was there to witness his last known well time and she was able to notify first responders. They arrived quickly and he was able to receive t-PA in a timely manner. With the help of the interdisciplinary team consisting of nurses, therapists, doctors, and other personnel, Randall was put on the path to not only recover from the stroke but also to quickly regain function and quality of life very near to pre-stroke levels. It is now important that Randall continues to follow up with his primary doctor and his neurologist and that he adheres to his medication and physical therapy regimen.

Case Management

During Randall’s stay, Mary the case manager played a crucial role in Randall’s path to recovery. She determined that primary areas of concern included his history of medical noncompliance and unhealthy lifestyle. The case manager consulted with Dietary and requested that they provide Randall with education on a healthy diet regimen. She also provided him with smoking cessation information. Since Randall has been noncompliant with his medications, Mary determined that social services should consult with him to figure out what the reasons were behind his noncompliance. Social Services reported back to Mary that Randall stated that he didn’t really understand why he needed to take the medication. It was apparent that he had not been properly educated. Mary also needed to work with Randall’s insurance to ensure that he could go to the rehab facility as she knew this would greatly impact his ultimate outcome. Lastly, throughout his stay, the case manager provided Randall and his wife with resources on stroke educational materials. With the collaboration of nurses, education on the benefits of smoking cessation, medication adherence, lifestyle modifications, and stroke recognition was reiterated to the couple. After discharge, the case manager also checked up with Randall to make sure that he complied with his follow up appointments with the neurologist and physical and speech therapists,

• What risk factors contributed to Randall’s stroke?
• What types of contraindications could have prevented Randall from receiving t-PA?
• What factors attributed to Randall’s overall favorable outcome?

Nursing Case Studies by and for Student Nurses Copyright © by jaimehannans is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License , except where otherwise noted.

Share This Book

Case Presentation

Statement of ethics, conflict of interest statement, funding sources, author contributions, ischemic stroke in a 29-year-old patient with covid-19: a case report.

• Split-Screen
• Article contents
• Figures & tables
• Supplementary Data
• Peer Review
• Open the PDF for in another window
• Get Permissions
• Cite Icon Cite
• Search Site

Christian Avvantaggiato , Loredana Amoruso , Maria Pia Lo Muzio , Maria Assunta Mimmo , Michelina Delli Bergoli , Nicoletta Cinone , Luigi Santoro , Lucia Stuppiello , Antonio Turitto , Chiara Ciritella , Pietro Fiore , Andrea Santamato; Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report. Case Rep Neurol 2 September 2021; 13 (2): 334–340. https://doi.org/10.1159/000515457

Download citation file:

• Ris (Zotero)
• Reference Manager

Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic stroke. Elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events, and advanced age is strongly associated with severe COVID-19 and death. We reported, instead, a case of an ischemic stroke in a young woman during her hospitalization for COVID-19-related pneumonia. A 29-year-old woman presented to the emergency department of our institution with progressive respiratory distress associated with a 2-day history of fever, nausea, and vomiting. The patient was transferred to the intensive care unit (ICU) where she underwent a tracheostomy for mechanical ventilation due to her severe clinical condition and her very low arterial partial pressure of oxygen. The nasopharyngeal swab test confirmed SARS-CoV-2 infection. Laboratory tests showed neutrophilic leucocytosis, a prolonged prothrombin time, and elevated D-dimer and fibrinogen levels. After 18 days, during her stay in the ICU after suspension of the medications used for sedation, left hemiplegia was reported. Central facial palsy on the left side, dysarthria, and facial drop were present, with complete paralysis of the ipsilateral upper and lower limbs. Computed tomography (CT) of the head and magnetic resonance imaging of the brain confirmed the presence of lesions in the right hemisphere affecting the territories of the anterior and middle cerebral arteries, consistent with ischemic stroke. Pulmonary and splenic infarcts were also found after CT of the chest. The age of the patient and the absence of serious concomitant cardiovascular diseases place the emphasis on the capacity of SARS-CoV-2 infection to be an independent cerebrovascular risk factor. Increased levels of D-dimer and positivity to β2-glycoprotein antibodies could confirm the theory of endothelial activation and hypercoagulability, but other mechanisms – still under discussion – should not be excluded.

Coronavirus disease 2019 (COVID-19), caused by the novel coronavirus SARS-CoV-2, is characterized by a wide range of symptoms, most of which cause acute respiratory distress syndrome [1, 2], associated with intensive care unit (ICU) admission and high mortality [3]. On March 11, 2020, the large global outbreak of the disease led the World Health Organization (WHO) to declare COVID-19 a pandemic, with 11,874,226 confirmed cases and 545,481 deaths worldwide (July 9, 2020) [4]. In many cases, the clinical manifestations of COVID-19 are characteristic of a mild disease that may, however, worsen to a critical lower respiratory infection [2]. At the onset of the disease, the most frequent symptoms are fever, dry cough, fatigue, and shortness of breath as the infection progresses may appear signs and symptoms of respiratory failure that require ICU admission [5, 6]. Although acute respiratory distress syndrome is the most important cause of ICU admission for COVID-19 patients, several studies have underlined the presence of neurological symptoms such as confusion, dizziness, impaired consciousness, ataxia, seizure, anosmia, ageusia, vision impairment, and stroke [7, 8]. In particular, the state of hypercoagulability in patients affected by COVID-19 favors the formation of small and/or large blood clots in multiple organs, including the brain, potentially leading to cerebrovascular disease (ischemic stroke but also intracranial hemorrhage) [9, 10 ].

We found an interesting case of stroke following a SARS-CoV-2 infection in a young patient. A 29-year-old woman, during her ICU hospitalization for COVID-19-related pneumonia, was diagnosed with ischemic stroke of the right hemisphere, without other cardiac/cerebrovascular risk factors except hypertension. The young age of the patient and the absence of higher cerebrovascular risk factors make the present case very interesting as it can help demonstrate that COVID-19 is an independent risk factor for acute ischemic stroke. In a case series of 214 patients with COVID-19 (mean [SD] age, 52.7 [15.5] years), neurologic symptoms were more common in patients with severe infection who were older than the others [ 11 ]. New-onset CVD was more common in COVID-19 patients who had underlying cerebrovascular risk factors, such as older age (>65 years) [ 12 ], and very few cases of stroke in patients younger than 50 years have been reported [ 12, 13 ]. Our case seems to be the only one younger than 30 years.

On the night between March 19 and 20, 2020, a 29-year-old woman was referred to our hospital “Policlinico Riuniti di Foggia” due to a progressive respiratory distress associated with a 2-day history of fever, nausea, and vomiting. At presentation, the heart rate was 128 bpm, the blood oxygen saturation measured by means of the pulse oximeter was 27%, the respiratory rate was 27 breaths per minute, and the blood pressure was 116/77 mm Hg. The arterial blood gas test showed a pH of 7.52, pO 2 20 mm Hg, and pCO 2 34 mm Hg. The patient was immediately transferred to the ICU where she underwent tracheostomy and endotracheal intubation for mechanical ventilation due to her severe clinical condition and deteriorated pulmonary gas exchange. The diagnosis of COVID-19 was confirmed by PCR on a nasopharyngeal swab.

The family medical history was normal, and the only known pre-existing medical conditions were polycystic ovary syndrome (diagnosed 3 years earlier), conversion disorder, and hypertension (both diagnosed 2 years earlier). Ramipril and nebivolol were prescribed for the high blood pressure treatment, and sertraline was prescribed for the conversion disorder treatment. Drug therapy adherence was inconstant. The patient had no history of diabetes, cardiac pathologies, strokes, transient ischemic attacks, thromboembolic, or other vascular pathologies.

Laboratory tests showed neutrophilic leukocytosis (white blood cell count 14.79 × 10 3 , neutrophil percentage 89.8%, and neutrophil count 13.29 × 10 3 ), a prolonged prothrombin time (15.3 s) with a slightly elevated international normalized ratio (1.38), and elevated D-dimer (6,912 ng/mL) and fibrinogen levels (766 mg/dL). Other findings are shown in Table  1 .

Laboratory test

This pharmacological therapy was set as follows: enoxaparin 6,000 U.I. once a day, piperacillin 4 g/tazobactam 0.5 g twice a day; Kaletra, a combination of lopinavir and ritonavir indicated for human immunodeficiency virus (HIV) infection treatment, 2 tablets twice a day; hydroxychloroquine 200 mg once a day; and furosemide 250 mg, calcium gluconate, and aminophylline 240 mg 3 times a day. No adverse events were reported.

On April 7, 2020, during her stay in the ICU and after suspension of the medications used for sedation, left hemiplegia was reported. The same day, the patient underwent a computed tomography examination of the head, which showed areas of hypodensity in the right hemisphere due to recent cerebral ischemia.

On April 16, 2020, the patient was oriented to time, place, and person. Central facial palsy on the left side, dysarthria, and facial drop were present, with complete paralysis of the ipsilateral upper and lower limbs. The power of all the muscles of the left limbs was grade 0 according to the Medical Research Council (MRC) scale. Deep tendon reflexes were reduced on the left upper limb but hyperactive on the ipsilateral lower limb, with a slight increase in the muscle tonus. The senses of touch, vibration, and pain were reduced on the left side of the face and body.

On the same day, the patient underwent magnetic resonance imaging (MRI) of the brain (Fig.  1 a), showing lesions on the right hemisphere affecting the territories of the anterior and middle cerebral arteries. On May 5, 2020, magnetic resonance angiography showed an early duplication of the sphenoidal segment of the right middle cerebral artery, the branches of which are irregular with rosary bead-like aspects (Fig.  1 d, e); on the same day, the second MRI (Fig.  1 b) confirmed the lesions. Computed tomography of the chest (Fig.  1 c) and abdomen (Fig.  1 f), performed 5 days after the MRI of the brain, showed not only multifocal bilateral ground-glass opacities but also a basal subpleural area of increased density within the left lung (4 × 4 × 3 cm), consistent with a pulmonary infarction. In addition, a vascular lesion, consistent with a splenic infarct, was found in the inferior pole of the spleen. Doppler echocardiography of the hearth showed regular right chambers and left atrium and a slightly hypertrophic left ventricle with normal size and kinetics (ejection fraction: 55%). The age of the patient and the absence of serious concomitant cardiovascular diseases place the emphasis on the capacity of SARS-CoV-2 infection to be an independent cerebrovascular risk factor.

Imaging. a April 16, 2020; MRI of the brain: lesions in the right hemisphere affecting the territories of the anterior and the middle cerebral arteries. b May 5, 2020; MRI of the brain: same lesions in the right hemisphere shown in the previous image. d , e May 5, 2020; MRA showed an early duplication of the sphenoidal segment of the right middle cerebral artery, the branches of which are irregular with rosary bead-like aspect and reduction of blood flow in the middle cerebral artery. c April 20, 2020; CT of the abdomen: vascular lesion, consistent with a splenic infarct, found in the inferior pole of the spleen. f April 20, 2020; CT of the chest: basal subpleural area of increased density within the left lung (4 × 4 × 3 cm), consistent with a pulmonary infarction. MRA, magnetic resonance angiography; CT, computed tomography; MRI, magnetic resonance imaging.

The pandemic outbreak of novel SARS-CoV-2 infection has caused great concern among the services and authorities responsible for public health due to not only the mortality rate but also the danger of filling up hospital capacities in terms of ICU beds and acute non-ICU beds. In this regard, the nonrespiratory complications of COVID-19 should also be taken into great consideration, especially those that threaten patients’ lives and extend hospitalization times. Stroke is one of these complications, since a greater incidence of stroke among patients with COVID-19 than the non-COVID-19 population has been reported, and a preliminary case-control study demonstrated that SARS-CoV-2 infection represents a risk factor for acute ischemic stroke [ 14 ].

We found that the reported case is extremely interesting, since the woman is only 29 years old and considering how stroke in a young patient without other known risk factors is uncommon. Not only elderly people have higher risk factors associated with acute ischemic stroke or embolization vascular events [ 15 ], but it is also true that advanced age is strongly associated with severe COVID-19 and death. The severity of the disease is directly linked to immune dysregulation, cytokine storm, and acute inflammation state, which in turn are more common in patients who present immunosenescence [6].

Inflammation plays an important role in the occurrence of cardiovascular and cerebrovascular diseases since it favors atherosclerosis and affects plaque stability [ 16 ]. The ischemic stroke of the 29-year-old woman does not appear to be imputable to emboli originating a pre-existing atheromatous plaque, both for the age of the patient and for the absence of plaques at the Doppler ultrasound study of the supra-aortic trunks.

Most likely, COVID-19-associated hypercoagulability and endothelial dysfunction are the causes of ischemic stroke, as suggested by other studies and case reports [ 10, 13, 17 ]. Although the mechanisms by which SARS-CoV-2 infection leads to hypercoagulability are still being studied, current knowledge suggests that cross talk between inflammation and thrombosis has a crucial role [ 18 ]. The release of inflammatory cytokines leads to the activation of epithelial cells, monocytes, and macrophages. Direct infection of endothelial cells through the ACE2 receptor also leads to endothelial activation and dysfunction, expression of tissue factor, and platelet activation and increased levels of VWF and FVIII, all of which contribute to thrombin generation and fibrin clot formation [ 17 ]. The 29-year-old patient showed an increased level of D-dimer, which is a degradation product of cross-linked fibrin, indicating a global activation of hemostasis and fibrinolysis and conforming to the hypothesis of COVID-19-associated hypercoagulability. Endothelial activation and hypercoagulability are also confirmed by positivity to β2 glycoprotein antibodies. Anticardiolipin antibody and/or β2 glycoprotein antibody positivity has been reported in a few studies [ 17, 19, 20 ]. In addition, widespread thrombosis in SARS-CoV-2 infection could also be caused by neutrophil extracellular traps (NETs). Neutrophilia [ 21 ] and an elevated neutrophil-lymphocyte ratio [ 22 ] have been reported by numerous studies as predictive of worse disease outcomes, and recently, the contribution of NETs in the pathophysiology of COVID-19 was reported [ 23 ]. Thrombogenic involvement of NETs has been described in various settings of thrombosis, including stroke, myocardial infarction, and deep vein thrombosis [ 24 ]. The high neutrophil count found in our case does not exclude the hypothesis that NETs are involved in the pathogenesis of ischemic stroke.

Ischemic stroke in young patients without pre-existing cerebrovascular risk factors is very unusual. In this regard, our case of an ischemic stroke, reported in a 29-year-old woman, is very interesting. Although it is not possible to determine precisely when the thromboembolic event occurred, our case of stroke during COVID-19-related pneumonia seems to confirm that COVID-19 is an independent risk factor for acute ischemic stroke. The mechanisms by which coronavirus disease leads to stroke are still under study, but it is clear that hypercoagulability and endothelial activation play a key role. Testing for SARS-CoV-2 infection should be considered for patients who develop neurologic symptoms, but it is equally important to monitor COVID-19 patients during their hospitalization to find any neurological sign or symptom in a timely manner. Our case suggests that discovering neurological deficits in sedated patients promptly can be very difficult; for this reason, sedation in mechanically ventilated patients has to be considered only if strictly necessary. Performing serial laboratory testing and waking up the patient as soon as clinical conditions allow are strategies that should be taken into account.

Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the editor-in-chief of this journal.

The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

No funding was received for the publication of this case report.

All authors agree with the contents of the manuscript and were fully involved in the study and preparation of the manuscript. All authors read and approved the final version of the manuscript. M.A. Mimmo, M.P. Lo Muzio, M. Delli Bergoli, and L. Amoruso collected the data. C. Avvantaggiato wrote the manuscript with support of N. Cinone, L. Santoro, and C. Ciritella. C. Avvantaggiato, A. Turitto, and L. Stuppiello researched and discussed the neurophysiological principles of this study. P. Fiore and A. Santamato supervised the project.

Email alerts

Citing articles via, suggested reading.

• Online ISSN 1662-680X

INFORMATION

• Contact & Support
• Information & Downloads
• Rights & Permissions
• Terms & Conditions
• Catalogue & Pricing
• Policies & Information
• People & Organization
• Stay Up-to-Date
• Regional Offices
• Community Voice

SERVICES FOR

• Researchers
• Healthcare Professionals
• Patients & Supporters
• Health Sciences Industry
• Medical Societies
• Agents & Booksellers

Karger International

• S. Karger AG
• P.O Box, CH-4009 Basel (Switzerland)
• Allschwilerstrasse 10, CH-4055 Basel
• Tel: +41 61 306 11 11
• Fax: +41 61 306 12 34
• Contact: Front Office
• Experience Blog
• Privacy Policy
• Terms of Use

This Feature Is Available To Subscribers Only

Sign In or Create an Account

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

• Publications
• Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

• Advanced Search
• Journal List

Stroke in young adults, stroke types and risk factors: a case control study

Priscilla namaganda.

1 Kiruddu National Referral Hospital, P.O. Box 6553, Kampala, Uganda

Jane Nakibuuka

2 Mulago National Referral Hospital, Mulago Hospital Complex, P.O. Box 7272, Kampala, Uganda

Mark Kaddumukasa

3 Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda

Elly Katabira

4 Infectious Diseases Institute, Makerere University, Kampala, Uganda

Associated Data

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Stroke is the second leading cause of death above the age of 60 years, and the fifth leading cause in people aged 15 to 59 years old as reported by the World Health Organization global burden of diseases. Stroke in the young is particularly tragic because of the potential to create long-term disability, burden on the victims, their families, and the community at large. Despite this, there is limited data on stroke in young adults, and its risk factors in Uganda. Therefore, we determined the frequency and risk factors for stroke among young adults at Mulago hospital.

A case control study was conducted among patients presenting consecutively to the general medical wards with stroke during the study period September 2015 to March 2016. A brain Computerized Tomography scan was performed to confirm stroke and classify the stroke subtype. Controls were patients that presented to the surgical outpatient clinic with minor surgical conditions, matched for age and sex. Social demographic, clinical and laboratory characteristics were assessed for both cases and controls. Descriptive statistics including frequencies, percentages, means, and standard deviation were used to describe the social demographics of case and controls as well as the stroke types for cases. To determine risk factors for stroke, a conditional logistic regression, which accounts for matching (e.g., age and sex), was applied. Odds ratio (with 95% confidence interval) was used as a measure for associations.

Among 51 patients with stroke, 39(76.5%) had ischemic stroke and 12(23.5%) had hemorrhagic stroke. The mean age was 36.8 years (SD 7.4) for stroke patients (cases) and 36.8 years (SD 6.9) for controls. Female patients predominated in both groups 56.9% in cases and 52.9% in controls. Risk factors noted were HIV infection, OR 3.57 (95% CI 1.16–10.96), elevated waist to hip ratio, OR 11.59(95% CI 1.98–68.24) and sickle cell disease, OR 4.68 (95% CI 1.11–19.70). This study found a protective effect of oral contraceptive use for stroke OR 0.27 95% CI 0.08–0.87. There was no association between stroke and hypertension, diabetes, and hyperlipidemia.

Among young adults with stroke, ischemic stroke predominated over hemorrhagic stroke. Risk factors for stroke were HIV infection, elevated waist to hip ratio and sickle cell disease.

Stroke is the second leading cause of death above the age of 60 years, and the fifth leading cause in people aged 15 to 59 years old as reported by the World Health Organization (WHO) global burden of diseases [ 1 ]. The severity of stroke in the young is relatively low in developed countries ranging from 2 -7% in Italy and USA respectively [ 2 , 3 ]. In Africa, on the other hand the prevalence of stroke among young adults is 12.9% in Nigeria [ 4 ], 31% in South Africa [ 5 ], 28.9% in Morocco [ 6 ]. The incidence of ischemic stroke in the young has been increasing globally over the last 2–3 decades. From the Danish National Patient Register, the incidence rates of first‐time hospitalizations for ischemic stroke and transient ischemic attack (TIA) in young adults have increased substantially since the mid 1990s while the incidences of hospitalizations for intracerebral hemorrhage and subarachnoid hemorrhage remained stable during the study period [ 7 ].

In Uganda, literature on stroke in young adults is limited however results of a study done among acute stroke patients admitted to the national referral hospital (Mulago hospital) showed a 30-day mortality of 43.8%. Out of 133 patients, 32 patients (25%) were less than 51 years old. Out of the 56 patients that died, 13 patients (23%) were less than 51 years [ 8 ].

Rapid western cultural adaption (sedentary lifestyle, deleterious health behavior like consumption of tobacco and alcohol and high fat/cholesterol diet) and Human immunodeficiency syndrome/ Acquired immunodeficiency syndrome (HIV/AIDS) that is highly prevalent in Africa has accelerated risk factors and increased the burden of stroke [ 9 ].

Most literature indicates that the traditional risk factors i.e., hypertension, diabetes mellitus and dyslipidemia are still the commonest risk factors with hypertension having the highest frequency. Other risk factors common to the young include smoking, excessive alcohol intake, illicit drug use, oral contraceptive use and migraine [ 10 ].

Although stroke is predominantly a disease of the middle age and the elderly, its occurrence in younger age groups is not rare. Stroke in young adults seems to be increasing and is particularly tragic because of the potential to create long-term disability, burden on the victims, their families, and the community at large such as Uganda. Despite the huge socioeconomic impact of stroke in this age group, there is a scarcity of data regarding stroke in young adults in sub-Saharan Africa including Uganda. Effective stroke prevention strategies in the young require comprehensive information on risk factors and possible causes. Although case reports and etiologic investigations of possible causes of stroke in the young have been identified especially in developed countries, there is limited data on risk factors in Africa Uganda inclusive. Information obtained from this study will fill the knowledge gap in this area of stroke in the young which will inform institutional strategies on prevention and management of stroke in this age group. This study, therefore, seeks to determine the frequency of stroke types and risk factors for this population.

The aims of the study were:

• To determine the frequency of stroke types among young adults on the general medical wards in Mulago hospital between September 2015 and March 2016.
• To determine the risk factors for stroke (i.e., ischemic, and hemorrhagic stroke) among young adults on the general medical wards in Mulago hospital between September and March 2016.

This was a case control study. Cases were defined as patients with a confirmed diagnosis of stroke by brain computerized tomography (CT) scan that met the inclusion criteria. Controls were defined as patients with minor surgical conditions that met the inclusion criteria. The study was carried out in Mulago hospital which is the national referral hospital in Uganda as well as the teaching hospital of Makerere University College of health sciences. It has a bed capacity of 1500 beds and has both inpatient wards, outpatient departments both for medical and surgical specialties. It has a radiological department with CT scan and highly trained personnel and a well-equipped laboratory. Cases were recruited consecutively from the medical wards specifically on the neurology ward of Mulago hospital. Patients on the neurology ward are managed by physicians that have had additional training in the management of neurological conditions.

Controls were recruited from general surgical outpatient departments from Mulago hospital. They were matched for age and sex. Eligible patients were patients aged 15–45 years, confirmed diagnosis of stroke on brain CT scan and with a written informed consent or assent for patients less than 18 years. These included patients with intracranial hemorrhages and ischemic stroke, none had subarachnoid hemorrhage. Patients were excluded if they were unconscious and with no valid surrogate (next of kin) and HIV positive with opportunistic infections. Patients eligible as control were, patient aged 15–45 years, minor surgical condition, written informed consent or assent for patients less than 18 years. Patients with features of stroke secondary to non-vascular causes like trauma, tumors were excluded as controls. For controls, we chose patients with minor surgical conditions because we wanted controls to be hospital patients but with non-medical conditions that could confound our findings. Such conditions included lacerations, hernias, lipomas, ingrown toenails, circumcision.

Based on the catchment area of Mulago, patients with minor surgical conditions are likely to have similar social economic status and come from similar neighborhoods as would health controls living in the catchment areas as patients with stroke.

The best alternative would have been healthy controls from the neighborhoods of the patients with stroke, but this would have been resource consuming.

The sample size was calculated assuming a prevalence of 62.2% of hypertension among the stroke patients as was indicated in a similar study among the young Thai adults in Bangkok, Thailand (Bandasak et al., 2011) [ 11 ]. We also assumed that the risk for stroke is higher among the hypertensive with an OR of 3. With this sample size, we were powered to detect associations with other risk factors like smoking (OR 2.6) [ 12 ], diabetes (OR 13.2 for black men and 22.1 for black women) [ 13 ].

With these assumptions, a sample size of 51 cases and 51 controls was found sufficient with 80% power and 0.05 level of significance.

Sampling procedure

All young patients admitted on the general medical wards suspected of having stroke were screened and brain CT scan done. Once a diagnosis of stroke was confirmed on CT scan, participants who consented to participate in the study were recruited consecutively, a standardized questionnaire administered by the research team for those patients able to communicate. For patients not able to communicate, consent and information were obtained through the care givers. Controls were selected from the general surgical outpatient clinic using consecutive sampling method. This was done after we had obtained all the cases. These were matched for age and sex until the sample size was accrued.

Information was collected on:

• Social demographic characteristics i.e., age, sex, level of education, occupation, religion, history of smoking and alcohol consumption, history of illicit drug use, history of oral contraceptive use.

Physical measurements for the weight and hip were taken using a stretchable tape measure. Waist measurements were taken at the narrowest point-umbilicus and hip measurements at the widest point- buttocks. A waist to hip ratio was obtained and recorded on the questionnaire.

• Blood was drawn for laboratory tests; high density lipoprotein, low density lipoprotein (HDL/LDL), fasting blood sugar, full blood count, Hb electrophoresis, prothrombin time/ international normalization ratio (PT/INR), HIV serology, Treponema pallidum hemagglutination (TPHA).

The general surgical outpatient clinic runs every Tuesday, and Thursday in Old Mulago hospital Participants were identified at the surgical outpatient clinic. Those matching the age and sex of the cases were recruited, written consent/assent obtained, and questionnaire was administered by the PI. The procedure as explained above was followed for the controls.

Data collection

A pre-tested and standardized questionnaire was used as a data collection tool. The principal investigator administered the questionnaire to the participants in data collection. Data on socio demographics and past medical history was collected.

Results from imaging and laboratory investigations were also recorded into the questionnaire.

Data collected was double entered into the computer using EPI-DATA (version 3.1) software to minimize data entry errors. Data was then backed up and archived in both soft and hard copy to avoid losses. Confidentiality was ensured using code numbers instead of patients’ names. Questionnaires were stored in a lockable cabinet for safety.

Data analysis

Data was analyzed using STATA Version 12 (StataCorp. 2011.  Stata Statistical Software: Release 12 . College Station, TX: StataCorp LP). Descriptive statistics were used to describe characteristics of the study participants and the stroke subtypes which included frequencies, percentages, means and standard deviation. To determine factors associated with stroke, a conditional logistic regression, which accounts for matching (e.g., age and sex), was applied. Odds ratio (with 95% confidence interval) was used as a measure for associations. Factors with p -values < 0.2 at a bi-variable analysis were entered into a multiple conditional logistic regression to obtain the adjusted estimates. Factors whose 95% confidence interval for the odds ratio that excludes a 1 or whose p -value < 0.05, were considered statistically significant at the adjusted level. Post-hoc power calculation was performed for the adjusted analysis to check if there was enough power to detect a difference between cases and controls.

Quality control

To ensure quality of results several measures were undertaken, these included:

• The questionnaires were pre-tested and standardized before study commenced.
• The research team administered the structured, pre- coded and pre-tested questionnaire to enrolled participants on a face-to-face basis and brain CT scans were done by competent and well-trained radiology technicians and interpretation done by a specialist radiologist at the Radiology Department of Mulago hospital.
• The questionnaires were checked for completeness at the end of every interview. The two files were compared, and any discordance corrected against data recorded with the questionnaire. The data were then backed up.

Ethical consideration

Written informed consent/ assent was obtained from all participants or their parent/guardian or legal authorized representative to participate in the study. Ethical approval was obtained from Makerere University, school of medicine research and ethics committee (SOMREC) (reference number #REC REF 2015–105).

Confidentiality was ensured using code numbers instead of patients’ names. Questionnaires were stored in a lockable cabinet for safety.

Profile of the study

Enrollment of study participants was carried out between September 2015 to March 2016 in Mulago hospital. The patient flow diagram for cases and controls is as shown in Fig.  1 .

Patient flow diagram

Social demographic characteristics of the study population

A total of 51 cases aged 18 to 45 years and the same number of hospital control matched for age and sex were identified. The mean age of cases was 36.8 years (standard deviation (SD) 7.4) and the control was 36.8 years (SD 6.9). Females predominated in both groups with 56.9% in cases and 52.9% in controls. There was no significant difference in other baseline characteristics between cases and controls except in oral contraceptive use, waist to hip ratio, HIV status and sickle cell disease. Details of the social demographic characteristics are shown in Table ​ Table1 1 .

Social Demographic characteristics of study participants

Clinical characteristics of the study participants

The mean fasting blood sugar was 6.6 (SD 3.9) for cases and 5.3 (SD 0.7) for controls. This was statistically significant with a p value of 0.015. Waist to hip ratio was also statistically significant with a p value of 0.007. Cases with an elevated wait to hip ratio were 14 (27.5%) and controls were 3 (5.9%). Table ​ Table2 2 shows the baseline clinical characteristics of the study participants.

Laboratory characteristics of the study participants

HIV serology and Hb electrophoresis were statistically significant with a p value of 0.076 and 0.023 respectively. 18 patients (35.3%) were reactive for HIV among cases and controls 10 (19.6%). 12 patients (23.5%) had abnormal Hb electrophoresis among cases controls 3 (5.9%). Table ​ Table3 3 shows the laboratory characteristics of the study participants.

Stroke types

Stroke types by social demographic characteristics of cases.

Among 62 patients, who had brain CT scan done, 11 patients had non stroke pathologies (4 had brain abscesses, 7 patients had ring enhancing lesions suggestive of toxoplasmosis). Among 51 patients with stroke confirmed on CT scan, the frequency of ischemic stroke was 76.5% and hemorrhagic stroke was 23.5%.

Most participants with ischemic or hemorrhagic stroke were in the age group 36–45 years. Females predominated in both ischemic and hemorrhagic stroke. Details of the social demographic characteristics by stroke types are shown in Table ​ Table4 4 .

Social demographic characteristics by stroke types

Clinical and laboratory characteristics by stroke types

Majority of patients with hemorrhagic stroke were hypertensive (91.7%) compared to only 25.6% among patients with ischemic stroke. Details of the clinical and laboratory characteristics of the study participants by stroke subtypes are shown in Table ​ Table5 5 .

Shows the clinical and laboratory characteristics by stroke types

Risk factors for stroke at univariate analysis

Social demographic characteristics at univariate analysis

Oral contraceptive use showed a significant difference with an unadjusted OR of 0.27 (95% CI 0.08–0.87) case subjects 23.3% and control subjects 56.5%. Belonging to other religion (seventh day advent, Pentecostal) was statistically significant with a p value of 0.009, OR 0.17. These findings are detailed in Table ​ Table6 6 below.

a Obtained accounting for matching by age and sex using a conditional logistic regression

b No comparison made because matching was done using these variables (age and sex)

c Accounting for matching was done only for age because contraceptive use applies only to female gender

Clinical characteristics at univariate analysis

There was a significant difference in waist to hip ratio between cases (27.5%) and controls (5.9%), with unadjusted OR 6.85 (CI 1.70–27.62). HIV serology with an unadjusted OR of 2.64 (95% CI 1.03–6.82). Hb electrophoresis with an unadjusted OR of 4.31 (95% CI- 1.15–16.17). Fasting blood sugar with an unadjusted OR of 1.64 (95% CI 1.02–2.62). Details of the above findings are shown in Table ​ Table7 7 below.

Clinical characteristics of study participants at univariate analysis

b Obtained by adding a 1 on each cell count (due to zero cell count)

c High (male: > 0.95, female > 0.85); Normal (male: < 0.95, female < 0.85)

Risk factors for stroke at multivariate analysis

At multivariate analysis, HIV serology (OR 3.72, 95% CI 1.16–10.96), waist to hip ratio (OR 11.26 95% CI 1.98–68.24) and sickle cell disease OR 4.78 95% CI 1.11–19.70) were independent risk factors for stroke in young adults. Table ​ Table8 8 shows risk factors at multivariate analysis. None of the patients with HIV met the definition of AIDS as defined by the occurrence of any of the more than 20 life-threatening cancers or “opportunistic infections”, by WHO.

a High (male: > 0.95, female > 0.85); Normal (male: < 0.95, female < 0.85)

b Obtained accounting for matching by age and sex using a conditional logistic regression

Variables with p value < 0.2 included in multivariant analysis include fasting blood sugar, hypertension, family of diabetes mellitus, waist to hip ratio, leucocyte count, HIV serology, sickle cell disease and oral contraceptive use

This case–control study showed that the frequency of ischemic stroke was higher than that of hemorrhagic stroke in young Ugandan population. We showed that positive HIV serology, elevated waist to hip ratio and sickle cell disease were independent risk factors for stroke in this population.

This is consistent with several studies that have been done and found ischemic stroke to be more prevalent than hemorrhagic stroke. Studies done in Africa, in Libya reported 77% ischemic stroke and 23% hemorrhagic stroke (these included both intracerebral and subarachnoid hemorrhagic stroke) [ 14 ], in Morocco, 87.3% ischemic stroke and 12.7% hemorrhagic (study did not specify on the subtypes of hemorrhagic stroke) [ 6 ]. In a study from Bosnia and Herzegovina, Subarachnoid hemorrhage was more frequent in young adults compared with older patients (> 45 years of age) (22% vs. 3.5%), intracerebral hemorrhage (ICH) was similar in both groups (16.9% vs. 15.8%), but ischemic stroke (IS) was predominant stroke type in the older group (61% vs. 74%) [ 15 ]. On the other hand, studies focusing on all young stroke patients and including also subarachnoid hemorrhages have found much higher proportion of hemorrhagic strokes in younger vs. older individuals. Population-based studies have reported as low as 57% prevalence for ischemic stroke in those aged > 45, as reported by a recent narrative review [ 16 ]. This difference in occurrence of stroke subtypes could be due to the low prevalence of hypertension in this population in our setting given that hypertension has been reported to be the commonest risk factor for hemorrhagic stroke.

Most previous studies of HIV and stroke have been retrospective, but the prospective studies in Africa and East Africa have reported the importance of HIV as a risk factor for stroke [ 17 ]. A recently published study done in Malawi, with defined cases and population controls and 99% ascertainment of HIV status, reported HIV infection as an independent risk factor for stroke. This study further found that patients who had started standard HIV treatment in the previous six months had a higher risk of stroke (OR 15.6 95% CI 4.21–46.6). This was probably due to an immune reconstitution inflammatory syndrome (IRIS) like process [ 18 ]. A variety of mechanisms have been implicated in the association of HIV and stroke, these include HIV associated vasculopathy, vasculitis which causes abnormality of the intracranial or extracranial cerebral blood vessels and neoplastic involvement. Indirectly through cardioembolic, coagulopathy in association with protein C and protein S deficiency. Some infections are well established causes of stroke, such as Mycobacterium tuberculosi s , syphilis, and varicella zoster virus through increased susceptibility to acquisition or reactivation of these infections [ 19 , 20 ]. Combined antiretroviral therapy (cART) might unmask occult opportunistic infections that subsequently cause a stroke. This possibility should be considered in all patients who have had an acute stroke or have worsening of stroke symptoms after initiation of cART [ 21 ].

An elevated waist to hip ratio (WHR) was associated with 12 times increased risk of stroke among young adults in Mulago hospital compared to individuals with a normal waist to hip ratio. Abdominal obesity (measured as waist–hip ratio) is associated with an increased risk of myocardial infarction, stroke, and premature death [ 22 ]. This agrees with a few studies that have assessed the association of stroke with waist to hip ratio. Aaron et al. 1990, assessed the relation between body fat distribution, and the 2-year incidences of hypertension and stroke in a cohort of 41,837 women aged 55–69 years. Women who developed stroke were 2.1 (95% CI 1.5–2.9) times more likely to have an elevated ratio than those who did not [ 23 ]. Md Habib et al. 2011 assessed high waist to hip ratio as a risk factor for ischemic stroke for overall stroke and he found 64% of the ischemic stroke patient had abnormal WHR in Bangladesh [ 24 ]. Abdominal obesity measured with WHR was an independent risk factor for cryptogenic ischemic stroke (CIS) in young adults after rigorous adjustment for concomitant risk factors in the Revealing the Etiology, Triggers, and Outcome (SECRETO; {"type":"clinical-trial","attrs":{"text":"NCT01934725","term_id":"NCT01934725"}} NCT01934725 ) study, a prospective case–control study that included patients aged 18–49 years with a first ever CIS at 19 European university centers [ 25 ].

Sickle cell disease was also associated with increased risk of stroke among young adults in Mulago hospital. This agrees with several studies that have associated sickle cell disease with stroke. Ohene et al. 1998 assessed cerebrovascular accidents (CVA) in sickle cell disease, found the highest rates of prevalence of 4.01% and incidence of 0.61 per 100 patient-years. The incidence of hemorrhagic stroke was highest among patients aged 20 to 29 years [ 26 ].

In our study, the unadjusted OR for oral contraceptive use was 0.26 95% CI 0.08–0.87 with a p value of 0.028. This observation at the unadjusted level is significant but could be due to another variable which is a confounder to OC use such as higher socioeconomic status and better control of other possible risk factors.

In our study, we found no association between hypertension and stroke in young adults though it’s an independent risk factor for stroke in the older population. This finding is different from the multinational interstroke study which attributed most strokes among young adults in low- and middle-income countries to hypertension. In that study, only one fifth of the patients were from wealthier African countries where hypertension, diabetes and hypercholesterolemia are likely to occur with higher prevalence than in Mulago hospital [ 27 ]. Other studies have also reported the role of hypertension as a risk factor for stroke in young adults, low physical activity and hypertension were the most important risk factors, accounting for 59.7% and 27.1% of all strokes, respectively among a German nationwide case–control study based on patients enrolled in the SIFAP1 study (Stroke in Young Fabry Patients) 2007 to 2010 and controls from the population-based GEDA study (German Health Update) 2009 to 2010 [ 28 ]. A study that used population-based controls for hospitalized young patients with ischemic stroke demonstrated that independent risk factors for stroke were atrial fibrillation (OR 10.43; cardiovascular disease (OR, 8.01; type 1 diabetes mellitus (OR, 6.72; type 2 diabetes mellitus (OR, 2.31, low high‐density lipoprotein cholesterol (OR, 1.81; current smoking status (OR, 1.81; hypertension (OR, 1.43, and a family history of stroke (OR, 1.37) [ 29 ].

This finding could be explained by the high prevalence of hypertension in the general peri urban Ugandan population among young adults as reported by Kayima et al. 2015. He found a prevalence of 15% (95% CI 14.2 – 19.6%) % for young adults aged 18–44 years [ 30 ].

The study was conducted at Mulago hospital which is a national referral hospital in Uganda situated in central Uganda. Mulago hospital received patients both referred patients from all over Uganda and those from its catchment area. This is generally representative of the whole Ugandan population.

Uganda has a young population and with an HIV prevalence comparable to most countries in Sub-Saharan Africa, so the findings of this study are generalizable to other Sub-Saharan African populations.

Ischemic stroke is more prevalent than hemorrhagic stroke among young adults in Mulago hospital. Independent risk factors for stroke among young adults in Mulago hospital were HIV infection, elevated waist to hip ratio and sickle cell disease. Oral contraceptive use was found to be protective of stroke among young adults in Mulago hospital. There was no significant association between stroke among young adults and hypertension, diabetes, hyperlipidemia, smoking, alcohol use and illicit use.

Study limitations

• The sample size was too small to detect all but the strongest associations with common exposures. When designing the study, we based on hypertension as a significant driver for strokes in this population based on other studies done to calculate the sample size, however based on our findings, hypertension was not a big driver of stroke in this population. Secondly the nature of stroke type associated with hypertension is hemorrhagic which were less common in this study. This was an unexpected finding and needs more evaluation.
• Consecutive sampling methods has selection bias in which a variable that is associated with the outcome under investigation may occur more frequently or less in those sampled in this period as compared to the general population.
• The use of a combined ischemic stroke and intracerebral hemorrhage group may have obscured relationships specific to one group, i.e., the risk factors for stroke were not stratified for type of stroke.
• The best alternative for controls would have been healthy controls from the neighborhoods of the patients with stroke, but this would have been resource consuming hence the choice of hospital controls with different medical conditions from cases.

Acknowledgements

We acknowledge the patients of Mulago hospital who gave us consent to obtain this information.

Authors’ contributions

PN– conception, design of work, acquisition, analysis, interpretation of data, drafted and substantively revised the manuscript, JN– analysis, interpretation of data, drafted and substantively revised the manuscript, MK – analysis, interpretation of data, drafted and substantively revised the manuscript, EK– design of work, acquisition, analysis, interpretation of data, drafted and substantively revised the manuscript. All authors read and approved the final manuscript.

This study was funded with funds from the MEPI-Neurology program under Makerere University. The funding project had no role in the design of the study and collection, analysis, and interpretation of data and no role in writing the manuscript.

Availability of data and materials

Declarations.

Written informed consent/ assent was obtained from all participants or their parent/guardian or legal authorized representative to participate in the study. Ethical approval was obtained from Makerere University, school of medicine research and ethics committee (SOMREC) (reference number #REC REF 2015–105). All methods and procedures were carried out in accordance with relevant guidelines and regulations.

Not applicable.

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Complete Your CE

Course case studies, external link, this link leads outside of the netce site to:.

While we have selected sites that we believe offer good, reliable information, we are not responsible for the content provided. Furthermore, these links do not constitute an endorsement of these organizations or their programs by NetCE, and none should be inferred.

Ischemic Stroke

Course #90284 - $60 -

#90284: Ischemic Stroke

Your certificate(s) of completion have been emailed to

• Back to Course Home
• Review the course material online or in print.
• Complete the course evaluation.
• Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.

Patient M is an active woman, 70 years of age, who lost consciousness and collapsed at home. Her daughter, who was visiting her at the time, did not witness the collapse but found her mother on the floor, awake, confused, and slightly short of breath. The daughter estimated that she called EMS within 5 minutes after the collapse, and EMS responded within 15 minutes. EMS evaluated Patient M, drew blood for a glucose level, and determined that she may have had a stroke. They notified the nearest designated comprehensive stroke center that they would be arriving with the patient in approximately 20 minutes. Patient M's daughter accompanied her.

The triage and transportation of an individual with suspected stroke should be similar to that for an individual with serious trauma, and treatment is recommended within 3 hours after the onset of stroke. Because of the limited time available for assessment and diagnosis before optimal treatment, the EMS dispatcher should notify EMS personnel immediately and coordinate transport of the individual to the closest emergency facility, preferably one that is a designated primary (or comprehensive) stroke care center.

On presentation in the emergency department, Patient M is immediately triaged. Because Patient M is still somewhat confused, her daughter is asked to provide information on the patient's history. The daughter reports that her mother had had an episode of sudden-onset numbness and tingling in the right limb, with slight confusion and slurred speech, 3 days previously. The episode lasted only 5 minutes, and Patient M had not called her primary care physician. Additional information provided by the daughter indicates that Patient M has been treated for hypertension for 10 years but notes that she is often not compliant with her antihypertensive medicine, a diuretic. The patient has never smoked, drinks occasionally, and is of normal weight.

Patient M has two significant risk factors for stroke; one is a long history of hypertension. More than two-thirds of individuals older than 65 years of age are hypertensive, and it is important for individuals with hypertension to have regular blood pressure screening and to maintain a blood pressure of less than 140/90 mm Hg. Antihypertension therapy has been found to reduce the incidence of stroke by 30% to 40%. Patient M's noncompliance with her antihypertension medicine likely includes her among the 65% of known hypertensive individuals in whom blood pressure is not controlled.

Patient M's previous episode of numbness, confusion, and slurred speech appears to be evidence of a TIA, another substantial risk factor for stroke. Research has shown that approximately 5% of patients will have an ischemic stroke within 7 days after a TIA. In addition, the risk of stroke within 7 days is doubled for patients with TIAs who did not seek treatment. As is the case for many individuals who have a TIA, Patient M did not seek medical attention because the clinical symptoms resolved quickly. However, research findings indicate that urgent treatment should be provided for TIAs, as early treatment for TIA and minor stroke has been shown to reduce the risk of early recurrent stroke by 80%.

On physical examination, Patient M's blood pressure is 150/95 mm Hg. She has pain in her left arm and a slight headache. There is a focal carotid bruit on the right. She is assessed with use of the NIHSS and found to have 1/5 weakness in the left upper and lower extremities and left visual/spatial neglect. The results of laboratory tests, including a complete blood count, prothrombin time, serum electrolyte levels, cardiac biomarkers, and renal function studies, are all within normal limits. CT of the head obtained about 45 minutes into her ED evaluation (1.5 to 2 hours since last well) indicates an occlusion in a branch of the right internal carotid artery with 50% narrowing due to atherosclerosis. An area of ischemia/infarction is visible in the right anterior cerebral hemisphere. There is no evidence of subarachnoid hemorrhage. Approximately 2.5 to 3 hours after Patient M collapsed at home, she is treated with IV rt-PA at a dose of 0.9 mg/kg. Twenty-four hours later, aspirin antiplatelet therapy is started at an initial dose of 325 mg, and a maintenance dose of 75 mg per day.

Many of the patient's symptoms, including her loss of consciousness, shortness of breath, pain, and headache, are nontraditional symptoms of stroke. Studies have demonstrated that nontraditional symptoms are more prevalent among women, often leading to a delay in the evaluation for stroke. EMS personnel and clinicians should be aware of the potential for nontraditional symptoms in women and carry out a diagnostic evaluation addressing a suspicion of stroke.

Patient M is eligible for thrombolytic therapy with rt-PA according to evidence-based guidelines developed by the AHA/ASA: her blood pressure is lower than 185/110 mm Hg, the onset of symptoms is less than 3 hours prior to the start of treatment, and the laboratory values are within normal limits. Antiplatelet therapy with aspirin 325 mg daily (versus anticoagulant therapy with warfarin) is recommended for treatment of patients with stroke or TIA due to intracranial atherosclerosis with 50% to 99% occlusion. Antiplatelet therapy is not recommended as an adjunctive therapy within 24 hours of thrombolytic therapy.

When Patient M's condition is stabilized, her primary care physician and consultant neurologist provide a referral for stroke rehabilitation, and a multidisciplinary rehabilitation team is formed to assess her rehabilitative needs, recommend the proper rehabilitation setting, and develop a treatment strategy tailored to her specific needs that includes daily antiplatelet therapy. Patient M is again assessed with the NIHSS, and the score is 12. The patient's cognitive and communication skills are intact on evaluation with the FIM, with the exception of the previously documented left visual/spatial neglect. The assessment also includes evaluation of the patient's risk for complications. Because of her spatial neglect, she is screened with the Berg Balance Scale and the Stops Walking When Talking test. The score on the Berg Balance Scale is 43, and Patient M does stop walking to engage in conversation. Psychosocial assessment includes screening with the Center for Epidemiologic Studies Depression (CES-D) Scale, as well as review of the medical history and conversations with the patient and her children; no signs of depression are present.

Patient M's score of 12 on the NIHSS falls within the range (6 to 15) that indicates she is likely to benefit from rehabilitation. Evaluating a stroke survivor's risk of complications is an important component of the overall assessment, and among the most common complications are falls, deep vein thrombosis, pressure ulcers, swallowing dysfunction, bladder and bowel dysfunction, and depressive symptoms. In assessing the risk of complications, the Berg Balance Scale appears to be the most appropriate screen for patients who are likely to fall, and a score of less than 45 is associated with a likelihood of falling. The risk of a fall is also increased when a patient stops walking to talk, as Patient M did, during the Stops Talking When Walking test.

Screening for signs of depression is also essential, as depression affects approximately 33% of stroke survivors. Signs of depression are subtle and may be vague. Several screening tools are available, but there is no universally accepted tool for use in the post-stroke setting. The CES-D was chosen in this case because it is easy to administer, is useful in older individuals, and has been found to be effective for screening in the stroke population, except for individuals who have aphasia. The diagnosis of depression in stroke survivors should be based on sources in addition to a formal screening tool, such as a medical evaluation, patient self-report, observation of patient behavior, patient history, and staff reports of changes in behavior and motivation.

The rehabilitation team discusses the results of the assessment with Patient M's daughter and son, both of whom live about 45 minutes away from the patient. Together, the team and the family members explore options to determine the best approach to rehabilitation. A decision is made to transfer Patient M to an inpatient stroke unit, and a rehabilitation program is developed. The nurse on the team discusses the program with Patient M and her children and explains the course of rehabilitation and the expectations. Rehabilitation will focus on an exercise program consisting of aerobic exercise, strength training, stretching, and coordination and balance activities.

Early initiation of rehabilitation is a particularly strong predictor of improved outcome, and rehabilitation in a stroke unit has been associated with improved quality of life, survival, and functional status at 5 years compared with a general healthcare facility. No studies have demonstrated the superiority of one rehabilitation setting over another, and the inpatient setting was chosen primarily to ensure consistent care, given how far away Patient M's children live, and the limited support she otherwise has for healthcare needs. Decisions about the setting and program for rehabilitation should be shared with family members, and family and other caregivers should be provided with educational resources about the rehabilitation process.

The exercise program developed for Patient M is designed to help her regain the ability to independently carry out activities of daily living safely and to regain a functional level of ambulation. The benefits of an exercise program include increasing fitness, strength, and flexibility; improving function; preventing injuries and falls; and reducing the risk of recurrent stroke.

Patient M gradually resumes the ability to function independently, and after more than 2 weeks in the stroke rehabilitation unit, the score on the NIHSS has improved to 5. Before she is discharged to her home, the rehabilitation team provides instructions for exercises to continue at home and recommends moderate physical activity as a secondary prevention measure. The team also educates Patient M about the importance of maintaining a normal blood pressure through use of her antihypertension medication and lifestyle modifications. At a follow-up visit with her primary care clinician at 3 months, Patient M's blood pressure is 135/80 mm Hg, and she reports that she has been compliant with her antihypertension medicine and antiplatelet therapy and is functioning well at home.

• About NetCE
• About TRC Healthcare
• Do Not Sell My Personal Information

Copyright © 2024 NetCE · Contact Us

A sample case study: Mrs Brown

On this page, social work report, social work report: background, social work report: social history, social work report: current function, social work report: the current risks, social work report: attempts to trial least restrictive options, social work report: recommendation, medical report, medical report: background information, medical report: financial and legal affairs, medical report: general living circumstances.

This is a fictitious case that has been designed for educative purposes.

Mrs Beryl Brown URN102030 20 Hume Road, Melbourne, 3000 DOB: 01/11/33

Date of application: 20 August 2019

Mrs Beryl Brown (01/11/33) is an 85 year old woman who was admitted to the Hume Hospital by ambulance after being found by her youngest daughter lying in front of her toilet. Her daughter estimates that she may have been on the ground overnight. On admission, Mrs Brown was diagnosed with a right sided stroke, which has left her with moderate weakness in her left arm and leg. A diagnosis of vascular dementia was also made, which is overlaid on a pre-existing diagnosis of Alzheimer’s disease (2016). Please refer to the attached medical report for further details.

I understand that Mrs Brown has been residing in her own home, a two-story terrace house in Melbourne, for almost 60 years. She has lived alone since her husband died two years ago following a cardiac arrest. She has two daughters. The youngest daughter Jean has lived with her for the past year, after she lost her job. The eldest daughter Catherine lives on the Gold Coast with her family. Mrs Brown is a retired school teacher and she and both daughters describe her as a very private woman who has never enjoyed having visitors in her home. Mrs Brown took much encouragement to accept cleaning and shopping assistance once a week after her most recent admission; however, she does not agree to increase service provision. Jean has Enduring Power of Attorney (EPOA) paperwork that indicates that Mrs Brown appointed her under an EPOA two years ago. She does not appear to have appointed a medical treatment decision maker or any other decision-supporter.

I also understand from conversations with her daughters that Jean and Mrs Brown have always been very close and that there is a history of long-standing conflict between Catherine and Jean. This was exacerbated by the death of their father. Both daughters state they understand the impact of the stroke on their mother’s physical and cognitive functioning, but they do not agree on a discharge destination. Mrs Brown lacks insight into her care needs and says she will be fine once she gets back into her own home. Repeated attempts to discuss options with all parties in the same room have not resulted in a decision that is agreeable to all parties.

Mrs Brown has a history of Alzheimer’s disease; type II diabetes – insulin dependent; hypertension; high cholesterol and osteoarthritis. She has had two recent admissions to hospital for a urinary tract infection and a fall in the context of low blood sugars. She is currently requiring one to two people to assist her into and out of bed and one person with managing tasks associated with post-toilet hygiene. She can walk slowly for short distances with a four-wheel frame with one person to supervise. She benefits from prompting to use her frame; she needs someone to cut her food and to set her up to eat and drink regularly and to manage her medication routine. She requires one person to assist her to manage her insulin twice daily.

The team believe that Mrs Brown’s capacity for functional improvement has plateaued in the last ten days. They recommend that it is in her best interests to be discharged to a residential care setting due to her need for one to two people to provide assistance with the core tasks associated with daily living. Mrs Brown is adamant that she wants to return home to live with Jean who she states can look after her. Jean, who has a history of chronic back pain, has required several admissions to hospital over the past five years, and states she wants to be able to care for her mother at home. Jean states she is reluctant to agree to extra services as her mother would not want this. Her sister Catherine is concerned that Jean has not been coping and states that given this is the third admission to hospital in a period of few months, believes it is now time for her mother to enter residential care. Catherine states that she is very opposed to her mother being discharged home.

Mrs Brown is at high risk of experiencing falls. She has reduced awareness of the left side of her body and her ability to plan and process information has been affected by her stroke. She is now requiring one to two people to assist with all her tasks of daily living and she lacks insight into these deficits. Mrs Brown is also at risk of further significant functional decline which may exacerbate Jean’s back pain. Jean has stated she is very worried about where she will live if her mother is to enter residential care.

We have convened two family meetings with Mrs Brown, both her daughters and several members of the multi-disciplinary team. The outcome of the first meeting saw all parties agree for the ward to provide personalised carer training to Jean with the aim of trialling a discharge home. During this training Jean reported significant pain when transferring her mother from the bed and stated she would prefer to leave her mother in bed until she was well enough to get out with less support.

The team provided education to both Jean and Catherine about the progressive impact of their mother’s multiple conditions on her functioning. The occupational therapist completed a home visit and recommended that the downstairs shower be modified so that a commode can be placed in it safely and the existing dining room be converted into a bedroom for Mrs Brown. Mrs Brown stated she would not pay for these modifications and Jean stated she did not wish to go against her mother’s wishes. The team encouraged Mrs Brown to consider developing a back-up plan and explore residential care options close to her home so that Jean could visit often if the discharge home failed. Mrs Brown and Jean refused to consent to proceed with an Aged Care Assessment that would enable Catherine to waitlist her mother’s name at suitable aged care facilities. We proceeded with organising a trial overnight visit. Unfortunately, this visit was not successful as Jean and Catherine, who remained in Melbourne to provide assistance, found it very difficult to provide care without the use of an accessible bathroom. Mrs Brown remains adamant that she will remain at home. The team is continuing to work with the family to maximise Mrs Brown’s independence, but they believe that it is unlikely this will improve. I have spent time with Jean to explore her adjustment to the situation, and provided her with information on community support services and residential care services. I have provided her with information on the Transition Care Program which can assist families to work through all the logistics. I have provided her with more information on where she could access further counselling to explore her concerns. I have sought advice on the process and legislative requirements from the Office of the Public Advocate’s Advice Service. I discussed this process with the treating team and we decided that it was time to lodge an application for guardianship to VCAT.

The treating team believe they have exhausted all least restrictive alternatives and that a guardianship order is required to make a decision on Mrs Brown’s discharge destination and access to services. The team recommend that the Public Advocate be appointed as Mrs Brown’s guardian of last resort. We believe that this is the most suitable arrangement as her daughters are not in agreement about what is in their mother’s best interests. We also believe that there is a potential conflict of interest as Jean has expressed significant concern that her mother’s relocation to residential care will have an impact on her own living arrangements.

Mrs Brown’s medical history includes Alzheimer’s disease; type II diabetes; hypertension; high cholesterol and osteoarthritis. She was admitted to Hume Hospital on 3 March 2019 following a stroke that resulted in moderate left arm and leg weakness. This admission was the third hospital admission in the past year. Other admissions have been for a urinary tract infection, and a fall in the context hypoglycaemia (low blood sugars), both of which were complicated by episodes of delirium.

She was transferred to the subacute site under my care, a week post her admission, for slow-stream rehabilitation, cognitive assessment and discharge planning.

Mrs Brown was diagnosed with Alzheimer’s disease by Dr Joanne Winters, Geriatrician, in April 2016. At that time, Mrs Brown scored 21/30 on the Standardised Mini-Mental State Examination (SMMSE). During this admission, Mrs Brown scored 15/30. I have undertaken cognitive assessment and agree with the diagnosis; further cognitive decline has occurred in the context of the recent stroke. There are global cognitive deficits, but primarily affecting memory, attention and executive function (planning, problem solving, mental flexibility and abstract reasoning). The most recent CT-Brain scan shows generalised atrophy along with evidence of the new stroke affecting the right frontal lobe. My assessments suggest moderate to severe mixed Alzheimer’s and vascular dementia.

While able to recall some key aspects of her financial affairs, including the general monetary value of her pension and regular expenses, Mrs Brown was unable to account for recent expenditure (for repairs to her home) or provide an estimate of its value, and had difficulty describing her investments. In addition, I consider that she would be unable to make complex financial decisions due to her level of cognitive impairment. Accordingly, I am of the view that Mrs Brown now lacks capacity to make financial decisions.

Mrs Brown states that she previously made an Enduring Power of Attorney (EPOA) but could no longer recall aspects of the EPOA, such as when it would commence and the nature of the attorney’s powers. Moreover, she confused the EPOA with her will. Her understanding of these matters did not improve with education, and therefore I consider that she no longer has capacity to execute or revoke an EPOA.

Mrs Brown acknowledges that she needs some assistance but lacks insight into the type of assistance that she requires, apart from home help for cleaning and shopping. She does not appreciate her risk of falling. She is unable to get in and out of bed without at least one person assisting her. She frequently forgets to use her gait aid when mobilising and is not able to describe how she would seek help in the event of falling. She is not able to identify or describe how she would manage her blood sugar levels, and this has not improved with education. Accordingly, I consider that she lacks capacity to make decisions about accommodation arrangements and services.

Mrs Brown does not agree with the treating team’s recommendation to move into residential care and maintains her preference to return home. This is in spite of a failed overnight trial at home with both her daughters assisting her. Unfortunately, she was unable to get out of bed to get to the toilet and required two people to assist her to do so in the morning. In light of these matters, and in the context of family disagreement regarding the matter, the team recommends that the Office of the Public Advocate be appointed as a guardian of last resort.

Reviewed 22 July 2022

• Hospitals & health services
• Public hospitals in Victoria
• Patient care
• Ambulance and patient transport
• Non-emergency patient transport
• Non-emergency patient transport review
• NEPT legislation and clinical practice protocols
• Non-emergency patient transport licensing
• NEPT licensing fees
• NEPT services information and guidance
• First Aid Services
• First aid licences
• First aid services information and guidance
• First aid service fees
• Victorian State Trauma System
• Acute medicine
• Emergency care
• Surgical services
• Better at Home
• Critical care
• Hospital in the Home
• Virtual care (Telehealth)
• Perinatal and reproductive services
• Rehabilitation and complex care
• Renal health
• Renal services in Victoria
• Funding for renal services
• Different approaches to haemodialysis
• Specialist clinics
• Access to non-admitted services
• Minimum referral information
• Communication toolkit
• Integrated care
• HealthLinks: Chronic Care
• Community Health Integrated Program (CHIP) guidelines
• Service coordination in Victoria
• Victorian integrated care online resources
• Specialist clinics programs
• Specialist clinics reform
• Specialty diagnostics, therapeutics and programs
• Older people in hospital
• End of life and palliative care in Victoria
• Voluntary assisted dying
• Quality, safety and service improvement
• Planned surgery recovery and reform program
• Digital Health
• Roadmap and Maturity Model
• Standards and guidelines
• Policies and frameworks
• Health Information Sharing Legislation Reform
• My Health Record
• Public hospital accreditation in Victoria
• Credentialing for senior medical staff in Victoria
• Clinical risk management
• Preventing infections in health services
• Healthy choices
• Victorian Perinatal Data Collection
• Rural health
• Improving Access to Primary Care in Rural and Remote Areas Initiative
• Rural x-ray services
• Rural health regions and locations
• Rural and regional medical director role
• Victorian Patient Transport Assistance Scheme
• Rural and isolated practice registered nurses
• Urgent care in regional and rural Victoria
• Private health service establishments
• Private hospitals
• Day procedure centres
• Mobile health services
• Fees for private health service establishments in Victoria
• Design resources for private health service establishments
• Professional standards in private health service establishments
• Legislation updates for private health service establishments
• Complaints about private health service establishments
• Cosmetic procedures
• Guideline for providers of liposuction
• Private hospital funding agreement
• Boards and governance
• About health service boards in Victoria
• Information and education
• Education resources for boards
• Sector leadership
• Data, reporting and analytics
• Health data standards and systems
• Funding, performance and accountability
• Statements of Priorities
• Performance monitoring framework
• Integrity governance framework and assessment tool
• Pricing and funding framework
• Patient fees and charges
• Fees and charges for admitted patients
• Non-admitted patients - fees and charges
• Other services
• Planning and infrastructure
• Sustainability in Healthcare
• Medical equipment asset management framework
• Health system design, service and infrastructure planning
• Complementary service and locality planning
• Primary & community health
• Primary care
• Community pharmacist pilot
• EOI - Victorian Community Pharmacist Statewide Pilot
• Victorian Community Pharmacist Statewide Pilot – Resources for pharmacists
• Emergency Response Planning Tool
• Working with general practice
• Victorian Supercare Pharmacies
• NURSE-ON-CALL
• Priority Primary Care Centres
• Local Public Health Units
• Community health
• Community health services
• Community health pride
• Registration and governance of community health centres
• Community Health Directory
• Community Health Program in Victoria
• Community health population groups
• Dental health
• Access to public dental care services
• Victoria's public dental care fees
• Victoria's public dental care waiting list
• Dental health for SRS residents
• Dental health program reporting
• Smile Squad school dental program
• Maternal and Child Health Service
• Nursery Equipment Program
• Maternal and Child Health Service Framework
• Maternal and Child Health Service resources
• Child Development Information System
• Early parenting centres
• Maternal Child and Health Reporting, Funding and Data
• Baby bundle
• Sleep and settling
• Maternal and Child Health Workforce professional development
• Aboriginal Maternal and Child Health
• Public Dental and Community Health Program funding model review
• Public health
• Women's Health and Wellbeing Program
• Inquiry into Women's Pain
• Inquiry into Women's Pain submissions
• Support groups and programs
• About the program
• Victorian Women's Health Advisory Council
• Cemeteries and crematoria
• Medicines and Poisons Regulation
• Patient Schedule 8 treatment permits
• Schedule 8 MDMA and Schedule 8 psilocybine
• Schedule 9 permits for clinical trials
• Documents and forms to print or download
• Legislation and Approvals
• Frequently Asked Questions - Medicines and Poisons Regulation
• Health practitioners
• Licences and permits to possess (& possibly supply) scheduled substances
• Medicinal cannabis
• Pharmacotherapy (opioid replacement therapy)
• Recent updates
• Environmental health
• Improving childhood asthma management in Melbourne's inner west
• Climate and weather, and public health
• Environmental health in the community
• Environmental health in the home
• Environmental health professionals
• Face masks for environmental hazards
• Human health risk assessments
• Lead and human health
• Per- and poly-fluoroalkyl substances (PFAS)
• Pesticide use and pest control
• Food safety
• Information for community groups selling food to raise funds
• Food businesses
• Food safety information for consumers
• Food regulation in Victoria
• Food safety library
• Food allergens
• Introducing Standard 3.2.2A: Food safety management tools
• Immunisation
• Respiratory syncytial virus (RSV) immunisation
• Seasonal influenza vaccine
• Immunisation schedule and vaccine eligibility criteria
• Ordering vaccine
• Immunisers in Victoria
• Immunisation provider information
• Cold chain management
• Adverse events following immunisation reporting
• Vaccine error management
• Vaccination for infants and children
• Vaccination for adolescents
• Vaccination program for adults
• Vaccination for special-risk groups
• Immunisation resources order form
• Victorian coverage rates for Victoria
• Infectious diseases guidelines & advice
• Infection control guidelines
• Disease information and advice
• Advice to the cruise industry: reporting infections
• Notifiable infectious diseases, conditions and micro-organisms
• Notification procedures for infectious diseases
• Infectious diseases surveillance in Victoria
• Germicidal ultraviolet light
• Protecting patient privacy in Victoria
• Population health systems
• Evidence and evaluation
• Health promotion
• Health status of Victorians
• Municipal public health and wellbeing planning
• Population screening
• Cancer screening
• Conditions not screened
• Improving outcomes in under-screened groups
• Infant hearing screening
• Newborn bloodspot screening
• Prenatal screening
• Screening registers
• Preventive health
• Type 2 diabetes and cardiovascular disease prevention
• Eye health promotion
• Injury prevention
• Healthy eating
• Oral health promotion
• Physical activity
• Sexual health
• Sex worker health
• Decriminalisation of sex work
• Automatic mutual recognition
• Domestic smoke detectors
• Lasers, IPL and LED devices for cosmetic treatments and beauty therapy
• Victoria's regulatory framework for radiation
• Radiation newsletter
• Tobacco reforms
• Tobacco reform legislation and regulations
• E-cigarettes and vaping
• Quitting smoking and vaping
• Smoke-free and vape-free areas
• Building entrances
• Children's indoor play centres
• Public hospitals and health centres
• Children's recreational areas
• Playground equipment
• Skate parks
• Swimming pools
• Under-age sporting events
• Enclosed workplaces
• Government buildings
• Learning environments
• Outdoor dining
• Outdoor drinking areas
• Patrolled beaches
• Train platforms and bus and tram shelters
• Under-age music or dance events
• Tobacco and e-cigarette retailers
• Making a report or complaint
• Resources and factsheets
• Alternative water supplies
• Aquatic facilities
• Blue-green algae (cyanobacteria)
• Drinking water in Victoria
• Legionella risk management
• Private drinking water
• Recreational water use and possible health risks
• Water fluoridation
• Chief Health Officer
• About the Chief Health Officer
• Chief Health Officer publications
• Health alerts and advisories
• Mental health
• Mental Health and Wellbeing Act 2022
• Mental Health and Wellbeing Act 2022 Handbook
• Community information
• Mental Health and Wellbeing Act 2022 in your language
• About Victoria's mental health services
• Area-based services
• Statewide and specialist mental health services
• Mental Health Community Support Services
• Support and intervention services
• Language services - when to use them
• Access to mental health services across areas
• Transport for people in mental health services
• Practice and service quality
• Medical Treatment Planning and Decisions Act
• Service quality
• Specialist responses
• Mental health and wellbeing reform
• Reform activity updates
• Priority areas
• Latest news
• Working with consumers and carers
• Consumer and carer engagement
• Consumer and Carer Experience Surveys
• Family support and crisis plans
• Consumer and carer financial support
• Supporting children whose parents have a mental illness
• Supporting parents with a mental illness
• Prevention and promotion
• Early intervention in mental illness
• Mental health promotion in Victoria
• Suicide prevention in Victoria
• Priorities and transformation
• Supporting the social and emotional wellbeing of Aboriginal and Torres Strait Islander Victorians
• National mental health strategy
• Rights and advocacy
• Making a complaint about a mental health service
• Chief Psychiatrist
• About the Chief Psychiatrist
• Principles in the Mental Health and Wellbeing Act and the Chief Psychiatrist's guidelines
• Obligations under the Mental Health and Wellbeing Act 2022
• Reporting a failure to comply with the Mental Health and Wellbeing Act 2022
• Governance and committees
• Reporting obligations for clinical mental health and wellbeing services
• Mental health and wellbeing support
• Making a complaint and seeking advocacy
• Second psychiatric opinion and process of review by Chief Psychiatrist
• Office of the Chief Psychiatrist's reform activities and news
• Oversight of forensic mental health and wellbeing services
• Resources and reports
• Chief psychiatrist guidelines
• Chief Mental Health Nurse
• About Victoria's Chief Mental Health Nurse
• Best practice
• Reducing restrictive interventions
• Research and reporting
• Mental health performance reports
• Reporting requirements and business rules for clinical mental health services
• Alcohol & drugs
• Alcohol and other drug treatment services
• Overview of Victoria's alcohol and drug treatment system
• Pathways into alcohol and other drugs treatment
• Prevention and harm reduction
• Medically supervised injecting room
• Victoria's Take-Home Naloxone Program
• Community-based AOD treatment services in Victoria
• Residential treatment services
• Mildura statewide alcohol and drug residential treatment service
• Drug rehabilitation plan
• Hospital-based services
• Forensic services
• Pharmacotherapy treatment
• Services for Aboriginal people
• Services for young people
• Statewide and specialist services
• Compulsory treatment
• Family and peer support
• Public intoxication reform
• New public intoxication response services
• Policy, research and legislation
• Alcohol and drug research and data
• Legislation governing alcohol and other drug treatment
• Alcohol and other drug service standards and guidelines
• Alcohol and other drug client charter and resources
• Alcohol and other drug treatment principles
• Service quality and accreditation
• Alcohol and other drug program guidelines
• Maintenance pharmacotherapy
• Specialist Family Violence Advisor capacity building program in mental health and alcohol and other drug services - Victoria
• Alcohol and other drug workforce
• Learning and development
• Alcohol and other drug workforce Minimum Qualification Strategy
• Workforce data and planning
• Funding and reporting for alcohol and other drug services
• Funding of alcohol and other drugs services in Victoria
• Reporting requirements and business rules for alcohol and other drug services
• Drug alerts
• 25C-NBOMe and 4-FA sold as '2C-B'
• Novel stimulants sold as MDMA, cocaine or speed
• Protonitazene sold as ketamine
• High potency benzodiazepine tablets
• MDMA adulterated with PMMA
• 25B-NBOH sold as powdered 'LSD'
• Green 'UPS' pills containing N-ethylpentylone (no MDMA)
• N-ethylpentylone in cocaine
• Ageing & aged care
• Supporting independent living
• Low cost accommodation support programs
• Personal Alert Victoria
• Dementia services
• Victorian Aids and Equipment Program
• Residential aged care services
• Public sector residential aged care services
• Safety and quality in public sector residential aged care
• Physical and social environments
• Emergency preparedness in residential aged care services
• My Aged Care assessment services
• Home and Community Care Program for Younger People
• HACC data reporting
• HACC PYP fees policy and schedule of fees
• Wellbeing and participation
• Age-friendly Victoria
• Healthy ageing
• Seniors participation
• Dementia-friendly environments
• Designing for people with dementia
• Maintaining personal identity
• Personal enjoyment
• Interior design
• Dining areas, kitchens and eating
• Bedrooms and privacy
• Gardens and outdoor spaces
• Assistive technology
• Staff education and support
• Strategies, checklists and tools
• Our Strategic Plan 2023-27
• Our organisation
• Our secretary
• Leadership charter
• Our services
• Our vision and values
• Specialist offices
• Senior officers in health
• Human Research Ethics Committee (HREC)
• Gifts, benefits and hospitality policy
• Information Asset Register
• Health legislation
• Health legislation overview
• Health Complaints legislation
• Health Records Act
• Human Tissue Act 1982
• Public Health and Wellbeing Act 2008
• Voluntary Assisted Dying Act
• Victoria's pandemic management framework
• Independent Pandemic Management Advisory Committee
• Pandemic Order Register
• Our ministers
• Our role in emergencies
• State Health Emergency Response Arrangements
• Emergency type
• Department's responsibilities in emergencies
• Health services’ responsibilities in emergencies
• Aboriginal employment
• Current vacancies
• Employment programs for students and graduates
• Rise program
• Inclusion and diversity at the Department of Health
• Health workforce
• Working in health
• Information sharing and MARAM
• Child Safe Standards
• Regulatory functions
• Reviews of decisions
• Victorian Public Healthcare Awards
• Aboriginal healthcare workers
• Mental health workforce
• Lived and living experience workforces
• Engaging with lived and living experience workforces
• Our workforce, our future
• Nursing and midwifery
• Free nursing and midwifery study
• Additional funding for nursing and midwifery positions
• Becoming a nurse or midwife
• Undergraduate nursing and midwifery scholarships
• Undergraduate student employment programs
• Nursing and midwifery graduates
• Nursing and midwifery graduate sign-on bonus
• Working as a nurse or midwife
• Enrolled nurse to registered nurse transition scholarships
• Support for new nurse practitioners
• Postgraduate scholarships for nurses and midwives
• Nurse practitioners
• Returning to nursing or midwifery
• Refresher pathway for nurses and midwives
• Re-entry pathway scholarships for nurses and midwives
• Nursing and midwifery - legislation and regulation
• Nursing and midwifery program - health sector
• Allied health workforce
• Education and training
• Enterprise agreements
• Worker health and wellbeing
• Working with us
• Grants and programs
• Freedom of Information
• Part II - Information Statements
• Procurement policies
• Protective markings
• Health and medical research
• Sponsorship application information
• Publications
• Annual reports
• Fact sheets
• Strategies, plans and charters
• Policies, standards and guidelines
• Research and reports
• Forms and templates
• Communities
• Designing for Diversity
• Vulnerable children
• Vulnerable children - responsibilities of health professionals
• Identifying and responding to children at risk
• Pathway to good health for children in care
• Older people
• Aboriginal health
• Improving health for Victorians from culturally and linguistically diverse backgrounds
• Asylum seeker and refugee health in Victoria
• News and media hub
• Media releases
• Health alerts
• Feedback and complaints
• Make a payment
• Fees, charges and penalties subject to automatic indexation
• Our campaigns

Share this page

• Facebook , opens a new window
• X (formerly Twitter) , opens a new window
• LinkedIn , opens a new window

This presents an analysis of a case of Ischemic stroke in terms of possible etiology, pathophysiology, drug analysis and nursing care

New? Questions? Start Here!

• Information Hub
• Important Notices
• Need Access to Evidence
• Communities & Collections
• Publication Date
• Posting Date
• Subject(CINAHL)
• Item Format
• Level of Evidence
• Research Approach
• Sigma Chapters
• Author Affiliations
• Review Type
• Create an Account

Ischemic stroke: A case study

View file(s).

Author Information

• Martinez, Rudolf Cymorr Kirby P. ;
• Sigma Affiliation

Item Information

Item link - use this link for citations and online mentions..

Clinical Focus: Adult Medical/Surgical

Repository Posting Date

Type information.

Category Information

Original Publication Info

Conference Information

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Log in using your username and password

• Search More Search for this keyword Advanced search
• Latest content
• Global health
• BMJ Journals

You are here

• Volume 13, Issue 8
• Clinical course of a 66-year-old man with an acute ischaemic stroke in the setting of a COVID-19 infection
• Article Text
• Article info
• Citation Tools
• Rapid Responses
• Article metrics

• http://orcid.org/0000-0002-7441-6952 Saajan Basi 1 , 2 ,
• Mohammad Hamdan 1 and
• Shuja Punekar 1
• 1 Department of Stroke and Acute Medicine , King's Mill Hospital , Sutton-in-Ashfield , UK
• 2 Department of Acute Medicine , University Hospitals of Derby and Burton , Derby , UK
• Correspondence to Dr Saajan Basi; saajan.basi{at}nhs.net

A 66-year-old man was admitted to hospital with a right frontal cerebral infarct producing left-sided weakness and a deterioration in his speech pattern. The cerebral infarct was confirmed with CT imaging. The only evidence of respiratory symptoms on admission was a 2 L oxygen requirement, maintaining oxygen saturations between 88% and 92%. In a matter of hours this patient developed a greater oxygen requirement, alongside reduced levels of consciousness. A positive COVID-19 throat swab, in addition to bilateral pneumonia on chest X-ray and lymphopaenia in his blood tests, confirmed a diagnosis of COVID-19 pneumonia. A proactive decision was made involving the patients’ family, ward and intensive care healthcare staff, to not escalate care above a ward-based ceiling of care. The patient died 5 days following admission under the palliative care provided by the medical team.

• respiratory medicine
• infectious diseases
• global health

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:  http://creativecommons.org/licenses/by-nc/4.0/ .

https://doi.org/10.1136/bcr-2020-235920

Statistics from Altmetric.com

Request permissions.

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is a new strain of coronavirus that is thought to have originated in December 2019 in Wuhan, China. In a matter of months, it has erupted from non-existence to perhaps the greatest challenge to healthcare in modern times, grinding most societies globally to a sudden halt. Consequently, the study and research into SARS-CoV-2 is invaluable. Although coronaviruses are common, SARS-CoV-2 appears to be considerably more contagious. The WHO figures into the 2003 SARS-CoV-1 outbreak, from November 2002 to July 2003, indicate a total of 8439 confirmed cases globally. 1 In comparison, during a period of 4 months from December 2019 to July 2020, the number of global cases of COVID-19 reached 10 357 662, increasing exponentially, illustrating how much more contagious SARS-CoV-2 has been. 2

Previous literature has indicated infections, and influenza-like illness have been associated with an overall increase in the odds of stroke development. 3 There appears to be a growing correlation between COVID-19 positive patients presenting to hospital with ischaemic stroke; however, studies investigating this are in progress, with new data emerging daily. This patient report comments on and further characterises the link between COVID-19 pneumonia and the development of ischaemic stroke. At the time of this patients’ admission, there were 95 positive cases from 604 COVID-19 tests conducted in the local community, with a predicted population of 108 000. 4 Only 4 days later, when this patient died, the figure increased to 172 positive cases (81% increase), illustrating the rapid escalation towards the peak of the pandemic, and widespread transmission within the local community ( figure 1 ). As more cases of ischaemic stroke in COVID-19 pneumonia patients arise, the recognition and understanding of its presentation and aetiology can be deciphered. Considering the virulence of SARS-CoV-2 it is crucial as a global healthcare community, we develop this understanding, in order to intervene and reduce significant morbidity and mortality in stroke patients.

• Download figure
• Open in new tab
• Download powerpoint

A graph showing the number of patients with COVID-19 in the hospital and in the community over time.

Case presentation

A 66-year-old man presented to the hospital with signs of left-sided weakness. The patient had a background of chronic obstructive pulmonary disease (COPD), atrial fibrillation and had one previous ischaemic stroke, producing left-sided haemiparesis, which had completely resolved. He was a non-smoker and lived in a house. The patient was found slumped over on the sofa at home on 1 April 2020, by a relative at approximately 01:00, having been seen to have no acute medical illness at 22:00. The patients’ relative initially described disorientation and agitation with weakness noted in the left upper limb and dysarthria. At the time of presentation, neither the patient nor his relative identified any history of fever, cough, shortness of breath, loss of taste, smell or any other symptoms; however, the patient did have a prior admission 9 days earlier with shortness of breath.

The vague nature of symptoms, entwined with considerable concern over approaching the hospital, due to the risk of contracting COVID-19, created a delay in the patients’ attendance to the accident and emergency department. His primary survey conducted at 09:20 on 1 April 2020 demonstrated a patent airway, with spontaneous breathing and good perfusion. His Glasgow Coma Scale (GCS) score was 15 (a score of 15 is the highest level of consciousness), his blood glucose was 7.2, and he did not exhibit any signs of trauma. His abbreviated mental test score was 7 out of 10, indicating a degree of altered cognition. An ECG demonstrated atrial fibrillation with a normal heart rate. His admission weight measured 107 kg. At 09:57 the patient required 2 L of nasal cannula oxygen to maintain his oxygen saturations between 88% and 92%. He started to develop agitation associated with an increased respiratory rate at 36 breaths per minute. On auscultation of his chest, he demonstrated widespread coarse crepitation and bilateral wheeze. Throughout he was haemodynamically stable, with a systolic blood pressure between 143 mm Hg and 144 mm Hg and heart rate between 86 beats/min and 95 beats/min. From a neurological standpoint, he had a mild left facial droop, 2/5 power in both lower limbs, 2/5 power in his left upper limb and 5/5 power in his right upper limb. Tone in his left upper limb had increased. This patient was suspected of having COVID-19 pneumonia alongside an ischaemic stroke.

Investigations

A CT of his brain conducted at 11:38 on 1 April 2020 ( figure 2 ) illustrated an ill-defined hypodensity in the right frontal lobe medially, with sulcal effacement and loss of grey-white matter. This was highly likely to represent acute anterior cerebral artery territory infarction. Furthermore an oval low-density area in the right cerebellar hemisphere, that was also suspicious of an acute infarction. These vascular territories did not entirely correlate with his clinical picture, as limb weakness is not as prominent in anterior cerebral artery territory ischaemia. Therefore this left-sided weakness may have been an amalgamation of residual weakness from his previous stroke, in addition to his acute cerebral infarction. An erect AP chest X-ray with portable equipment ( figure 3 ) conducted on the same day demonstrated patchy peripheral consolidation bilaterally, with no evidence of significant pleural effusion. The pattern of lung involvement raised suspicion of COVID-19 infection, which at this stage was thought to have provoked the acute cerebral infarct. Clinically significant blood results from 1 April 2020 demonstrated a raised C-reactive protein (CRP) at 215 mg/L (normal 0–5 mg/L) and lymphopaenia at 0.5×10 9 (normal 1×10 9 to 3×10 9 ). Other routine blood results are provided in table 1 .

CT imaging of this patients’ brain demonstrating a wedge-shaped infarction of the anterior cerebral artery territory.

Chest X-ray demonstrating the bilateral COVID-19 pneumonia of this patient on admission.

• View inline

Clinical biochemistry and haematology blood results of the patient

Interestingly the patient, in this case, was clinically assessed in the accident and emergency department on 23 March 2020, 9 days prior to admission, with symptoms of shortness of breath. His blood results from this day showed a CRP of 22 mg/L and a greater lymphopaenia at 0.3×10 9 . He had a chest X-ray ( figure 4 ), which indicated mild radiopacification in the left mid zone. He was initially treated with intravenous co-amoxiclav and ciprofloxacin. The following day he had minimal symptoms (CURB 65 score 1 for being over 65 years). Given improving blood results (declining CRP), he was discharged home with a course of oral amoxicillin and clarithromycin. As national governmental restrictions due to COVID-19 had not been formally announced until 23 March 2020, and inconsistencies regarding personal protective equipment training and usage existed during the earlier stages of this rapidly evolving pandemic, it is possible that this patient contracted COVID-19 within the local community, or during his prior hospital admission. It could be argued that the patient had early COVID-19 signs and symptoms, having presented with shortness of breath, lymphopaenia, and having had subtle infective chest X-ray changes. The patient explained he developed a stagnant productive cough, which began 5 days prior to his attendance to hospital on 23 March 2020. He responded to antibiotics, making a full recovery following 7 days of treatment. This information does not assimilate with the typical features of a COVID-19 infection. A diagnosis of community-acquired pneumonia or infective exacerbation of COPD seem more likely. However, given the high incidence of COVID-19 infections during this patients’ illness, an exposure and early COVID-19 illness, prior to the 23 March 2020, cannot be completely ruled out.

Chest X-ray conducted on prior admission illustrating mild radiopacification in the left mid zone.

On the current admission, this patient was managed with nasal cannula oxygen at 2 L. By the end of the day, this had progressed to a venturi mask, requiring 8 L of oxygen to maintain oxygen saturation. He had also become increasingly drowsy and confused, his GCS declined from 15 to 12. However, the patient was still haemodynamically stable, as he had been in the morning. An arterial blood gas demonstrated a respiratory alkalosis (pH 7.55, pCO 2 3.1, pO 2 6.7 and HCO 3 24.9, lactate 1.8, base excess 0.5). He was commenced on intravenous co-amoxiclav and ciprofloxacin, to treat a potential exacerbation of COPD. This patient had a COVID-19 throat swab on 1 April 2020. Before the result of this swab, an early discussion was held with the intensive care unit staff, who decided at 17:00 on 1 April 2020 that given the patients presentation, rapid deterioration, comorbidities and likely COVID-19 diagnosis he would not be for escalation to the intensive care unit, and if he were to deteriorate further the end of life pathway would be most appropriate. The discussion was reiterated to the patients’ family, who were in agreement with this. Although he had evidence of an ischaemic stroke on CT of his brain, it was agreed by all clinicians that intervention for this was not as much of a priority as providing optimal palliative care, therefore, a minimally invasive method of treatment was advocated by the stroke team. The patient was given 300 mg of aspirin and was not a candidate for fibrinolysis.

Outcome and follow-up

The following day, before the throat swab result, had appeared the patient deteriorated further, requiring 15 L of oxygen through a non-rebreather face mask at 60% FiO 2 to maintain his oxygen saturation, at a maximum of 88% overnight. At this point, he was unresponsive to voice, with a GCS of 5. Although, he was still haemodynamically stable, with a blood pressure of 126/74 mm Hg and a heart rate of 98 beats/min. His respiratory rate was 30 breaths/min. His worsening respiratory condition, combined with his declining level of consciousness made it impossible to clinically assess progression of the neurological deficit generated by his cerebral infarction. Moreover, the patient was declining sharply while receiving the maximal ward-based treatment available. The senior respiratory physician overseeing the patients’ care decided that a palliative approach was in this his best interest, which was agreed on by all parties. The respiratory team completed the ‘recognising dying’ documentation, which signified that priorities of care had shifted from curative treatment to palliative care. Although the palliative team was not formally involved in the care of the patient, the patient received comfort measures without further attempts at supporting oxygenation, or conduction of regular clinical observations. The COVID-19 throat swab confirmed a positive result on 2 April 2020. The patient was treated by the medical team under jurisdiction of the hospital palliative care team. This included the prescribing of anticipatory medications and a syringe driver, which was established on 3 April 2020. His antibiotic treatment, non-essential medication and intravenous fluid treatment were discontinued. His comatose condition persisted throughout the admission. Once the patients’ GCS was 5, it did not improve. The patient was pronounced dead by doctors at 08:40 on 5 April 2020.

SARS-CoV-2 is a type of coronavirus that was first reported to have caused pneumonia-like infection in humans on 3 December 2019. 5 As a group, coronaviruses are a common cause of upper and lower respiratory tract infections (especially in children) and have been researched extensively since they were first characterised in the 1960s. 6 To date, there are seven coronaviruses that are known to cause infection in humans, including SARS-CoV-1, the first known zoonotic coronavirus outbreak in November 2002. 7 Coronavirus infections pass through communities during the winter months, causing small outbreaks in local communities, that do not cause significant mortality or morbidity.

SARS-CoV-2 strain of coronavirus is classed as a zoonotic coronavirus, meaning the virus pathogen is transmitted from non-humans to cause disease in humans. However the rapid spread of SARS-CoV-2 indicates human to human transmission is present. From previous research on the transmission of coronaviruses and that of SARS-CoV-2 it can be inferred that SARS-CoV-2 spreads via respiratory droplets, either from direct inhalation, or indirectly touching surfaces with the virus and exposing the eyes, nose or mouth. 8 Common signs and symptoms of the COVID-19 infection identified in patients include high fevers, severe fatigue, dry cough, acute breathing difficulties, bilateral pneumonia on radiological imaging and lymphopaenia. 9 Most of these features were identified in this case study. The significance of COVID-19 is illustrated by the speed of its global spread and the potential to cause severe clinical presentations, which as of April 2020 can only be treated symptomatically. In Italy, as of mid-March 2020, it was reported that 12% of the entire COVID-19 positive population and 16% of all hospitalised patients had an admission to the intensive care unit. 10

The patient, in this case, illustrates the clinical relevance of understanding COVID-19, as he presented with an ischaemic stroke underlined by minimal respiratory symptoms, which progressed expeditiously, resulting in acute respiratory distress syndrome and subsequent death.

Our case is an example of a new and ever-evolving clinical correlation, between patients who present with a radiological confirmed ischaemic stroke and severe COVID-19 pneumonia. As of April 2020, no comprehensive data of the relationship between ischaemic stroke and COVID-19 has been published, however early retrospective case series from three hospitals in Wuhan, China have indicated that up to 36% of COVID-19 patients had neurological manifestations, including stroke. 11 These studies have not yet undergone peer review, but they tell us a great deal about the relationship between COVID-19 and ischaemic stroke, and have been used to influence the American Heart Associations ‘Temporary Emergency Guidance to US Stroke Centres During the COVID-19 Pandemic’. 12

The relationship between similar coronaviruses and other viruses, such as influenza in the development of ischaemic stroke has previously been researched and provide a basis for further investigation, into the prominence of COVID-19 and its relation to ischaemic stroke. 3 Studies of SARS-CoV-2 indicate its receptor-binding region for entry into the host cell is the same as ACE2, which is present on endothelial cells throughout the body. It may be the case that SARS-CoV-2 alters the conventional ability of ACE2 to protect endothelial function in blood vessels, promoting atherosclerotic plaque displacement by producing an inflammatory response, thus increasing the risk of ischaemic stroke development. 13

Other hypothesised reasons for stroke development in COVID-19 patients are the development of hypercoagulability, as a result of critical illness or new onset of arrhythmias, caused by severe infection. Some case studies in Wuhan described immense inflammatory responses to COVID-19, including elevated acute phase reactants, such as CRP and D-dimer. Raised D-dimers are a non-specific marker of a prothrombotic state and have been associated with greater morbidity and mortality relating to stroke and other neurological features. 14

Arrhythmias such as atrial fibrillation had been identified in 17% of 138 COVID-19 patients, in a study conducted in Wuhan, China. 15 In this report, the patient was known to have atrial fibrillation and was treated with rivaroxaban. The acute inflammatory state COVID-19 is known to produce had the potential to create a prothrombotic environment, culminating in an ischaemic stroke.

Some early case studies produced in Wuhan describe patients in the sixth decade of life that had not been previously noted to have antiphospholipid antibodies, contain the antibodies in blood results. They are antibodies signify antiphospholipid syndrome; a prothrombotic condition. 16 This raises the hypothesis concerning the ability of COVID-19 to evoke the creation of these antibodies and potentiate thrombotic events, such as ischaemic stroke.

No peer-reviewed studies on the effects of COVID-19 and mechanism of stroke are published as of April 2020; therefore, it is difficult to evidence a specific reason as to why COVID-19 patients are developing neurological signs. It is suspected that a mixture of the factors mentioned above influence the development of ischaemic stroke.

If we delve further into this patients’ comorbid state exclusive to COVID-19 infection, it can be argued that this patient was already at a relatively higher risk of stroke development compared with the general population. The fact this patient had previously had an ischaemic stroke illustrates a prior susceptibility. This patient had a known background of hypertension and atrial fibrillation, which as mentioned previously, can influence blood clot or plaque propagation in the development of an acute ischaemic event. 15 Although the patient was prescribed rivaroxaban as an anticoagulant, true consistent compliance to rivaroxaban or other medications such as amlodipine, clopidogrel, candesartan and atorvastatin cannot be confirmed; all of which can contribute to the reduction of influential factors in the development of ischaemic stroke. Furthermore, the fear of contracting COVID-19, in addition to his vague symptoms, unlike his prior ischaemic stroke, which demonstrated dense left-sided haemiparesis, led to a delay in presentation to hospital. This made treatment options like fibrinolysis unachievable, although it can be argued that if he was already infected with COVID-19, he would have still developed life-threatening COVID-19 pneumonia, regardless of whether he underwent fibrinolysis. It is therefore important to consider that if this patient did not contract COVID-19 pneumonia, he still had many risk factors that made him prone to ischaemic stroke formation. Thus, we must consider whether similar patients would suffer from ischaemic stroke, regardless of COVID-19 infection and whether COVID-19 impacts on the severity of the stroke as an entity.

Having said this, the management of these patients is dependent on the likelihood of a positive outcome from the COVID-19 infection. Establishing the ceiling of care is crucial, as it prevents incredibly unwell or unfit patients’ from going through futile treatments, ensuring respect and dignity in death, if this is the likely outcome. It also allows for the provision of limited or intensive resources, such as intensive care beds or endotracheal intubation during the COVID-19 pandemic, to those who are assessed by the multidisciplinary team to benefit the most from their use. The way to establish this ceiling of care is through an early multidisciplinary discussion. In this case, the patient did not convey his wishes regarding his care to the medical team or his family; therefore it was decided among intensive care specialists, respiratory physicians, stroke physicians and the patients’ relatives. The patient was discussed with the intensive care team, who decided that as the patient sustained two acute life-threatening illnesses simultaneously and had rapidly deteriorated, ward-based care with a view to palliate if the further deterioration was in the patients’ best interests. These decisions were not easy to make, especially as it was on the first day of presentation. This decision was made in the context of the patients’ comorbidities, including COPD, the patients’ age, and the availability of intensive care beds during the steep rise in intensive care admissions, in the midst of the COVID-19 pandemic ( figure 1 ). Furthermore, the patients’ rapid and permanent decline in GCS, entwined with the severe stroke on CT imaging of the brain made it more unlikely that significant and permanent recovery could be achieved from mechanical intubation, especially as the damage caused by the stroke could not be significantly reversed. As hospitals manage patients with COVID-19 in many parts of the world, there may be tension between the need to provide higher levels of care for an individual patient and the need to preserve finite resources to maximise the benefits for most patients. This patient presented during a steep rise in intensive care admissions, which may have influenced the early decision not to treat the patient in an intensive care setting. Retrospective studies from Wuhan investigating mortality in patients with multiple organ failure, in the setting of COVID-19, requiring intubation have demonstrated mortality can be up to 61.5%. 17 The mortality risk is even higher in those over 65 years of age with respiratory comorbidities, indicating why this patient was unlikely to survive an admission to the intensive care unit. 18

Regularly updating the patients’ family ensured cooperation, empathy and sympathy. The patients’ stroke was not seen as a priority given the severity of his COVID-19 pneumonia, therefore the least invasive, but most appropriate treatment was provided for his stroke. The British Association of Stroke Physicians advocate this approach and also request the notification to their organisation of COVID-19-related stroke cases, in the UK. 19

Learning points

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is one of seven known coronaviruses that commonly cause upper and lower respiratory tract infections. It is the cause of the 2019–2020 global coronavirus pandemic.

The significance of COVID-19 is illustrated by the rapid speed of its spread globally and the potential to cause severe clinical presentations, such as ischaemic stroke.

Early retrospective data has indicated that up to 36% of COVID-19 patients had neurological manifestations, including stroke.

Potential mechanisms behind stroke in COVID-19 patients include a plethora of hypercoagulability secondary to critical illness and systemic inflammation, the development of arrhythmia, alteration to the vascular endothelium resulting in atherosclerotic plaque displacement and dehydration.

It is vital that effective, open communication between the multidisciplinary team, patient and patients relatives is conducted early in order to firmly establish the most appropriate ceiling of care for the patient.

• Cannine M , et al
• Wunderink RG
• van Doremalen N ,
• Bushmaker T ,
• Morris DH , et al
• Wang X-G , et al
• Grasselli G ,
• Pesenti A ,
• Wang M , et al
• American Stroke Assocation, 2020
• Zhang Y-H ,
• Zhang Y-huan ,
• Dong X-F , et al
• Li X , et al
• Hu C , et al
• Zhang S , et al
• Jiang B , et al
• Xu J , et al
• British Association of Stroke Physicians

Contributors SB was involved in the collecting of information for the case, the initial written draft of the case and researching existing data on acute stroke and COVID-19. He also edited drafts of the report. MH was involved in reviewing and editing drafts of the report and contributing new data. SP oversaw the conduction of the project and contributed addition research papers.

Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests None declared.

Patient consent for publication Next of kin consent obtained.

Provenance and peer review Not commissioned; externally peer reviewed.

Read the full text or download the PDF:

Information

• Author Services

Initiatives

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess .

Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.

Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.

Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.

Original Submission Date Received: .

• Active Journals
• Find a Journal
• Proceedings Series
• For Authors
• For Reviewers
• For Editors
• For Librarians
• For Publishers
• For Societies
• For Conference Organizers
• Open Access Policy
• Institutional Open Access Program
• Special Issues Guidelines
• Editorial Process
• Research and Publication Ethics
• Article Processing Charges
• Testimonials
• Preprints.org
• SciProfiles
• Encyclopedia

Article Menu

• Subscribe SciFeed
• Recommended Articles
• Google Scholar
• on Google Scholar
• Table of Contents

Find support for a specific problem in the support section of our website.

Please let us know what you think of our products and services.

Visit our dedicated information section to learn more about MDPI.

JSmol Viewer

Exploring stroke patients’ needs: a cultural adaptation and validation of the modified needs assessment questionnaire in a greek context.

1. Introduction

2. materials and methods, 2.1. sample & data collection, 2.2. measures, 2.3. data analysis, 3.1. sample’s demographic characteristics, 3.2. scale validation, 3.3. confirmatory factor analysis & reliability analysis, 3.4. construct validity and nonparametric tests, 4. discussion, 5. conclusions, 6. limitations and future research, supplementary materials, author contributions, institutional review board statement, informed consent statement, data availability statement, conflicts of interest.

• Raftopoulos, V. Assessment of Users’ Expectations, Perceived Quality and Satisfaction with Primary Care in Greece. Int. J. Caring Sci. 2010 , 3 , 110–121. [ Google Scholar ]
• Kristensen, N.; Nymann, C.; Konradsen, H. Implementing Research Results in Clinical Practice—The Experiences of Healthcare Professionals. BMC Health Serv. Res. 2016 , 16 , 48. [ Google Scholar ] [ CrossRef ]
• Zawawi, N.S.M.; Aziz, N.A.; Fisher, R.; Ahmad, K.; Walker, M.F. The Unmet Needs of Stroke Survivors and Stroke Caregivers: A Systematic Narrative Review. J. Stroke Cerebrovasc. Dis. 2020 , 29 , 104875. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Kubina, L.-A.; Dubouloz, C.-J.; Davis, C.G.; Kessler, D.; Egan, M.Y. The Process of Re-Engagement in Personally Valued Activities during the Two Years Following Stroke. Disabil. Rehabil. 2013 , 35 , 236–243. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Arowoiya, A.; Elloker, T.; Karachi, F.; Mlenzana, N.; Jacobs-Nzuzi Khuabi, L.-A.; Rhoda, A. Using the World Health Organization’s Disability Assessment Schedule (2) to Assess Disability in Community-Dwelling Stroke Patients. S. Afr. J. Physiother. 2017 , 73 , 1–7. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Taule, T.; Råheim, M. Life Changed Existentially: A Qualitative Study of Experiences at 6–8 Months after Mild Stroke. Disabil. Rehabil. 2014 , 36 , 2107–2119. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Grefkes, C.; Grefkes, C.; Fink, G.R.; Fink, G.R. Recovery from Stroke: Current Concepts and Future Perspectives. Neurol. Res. Pract. 2020 , 2 , 17. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Kwakkel, G.; Kollen, B.; Twisk, J. Impact of Time on Improvement of Outcome After Stroke. Stroke J. Cereb. Circ. 2006 , 37 , 2348–2353. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Kristensen, H.K.; Tistad, M.; Von Koch, L.; Ytterberg, C. The Importance of Patient Involvement in Stroke Rehabilitation. PLoS ONE 2016 , 11 , e0157149. [ Google Scholar ] [ CrossRef ]
• Asplund, K.; Jonsson, F.; Eriksson, M.; Stegmayr, B.; Appelros, P.; Norrving, B.; Terént, A.; Hulter Åsberg, K. Patient Dissatisfaction with Acute Stroke Care. Stroke J. Cereb. Circ. 2009 , 40 , 3851–3856. [ Google Scholar ] [ CrossRef ]
• Hatem, S.M.; Saussez, G.; della Faille, M.; Prist, V.; Zhang, X.; Dispa, D.; Bleyenheuft, Y. Rehabilitation of Motor Function after Stroke: A Multiple Systematic Review Focused on Techniques to Stimulate Upper Extremity Recovery. Front. Hum. Neurosci. 2016 , 10 , 442. [ Google Scholar ] [ CrossRef ]
• Hartford, W.; Lear, S.; Nimmon, L. Stroke Survivors’ Experiences of Team Support along Their Recovery Continuum. BMC Health Serv. Res. 2019 , 19 , 723. [ Google Scholar ] [ CrossRef ]
• Olaleye, O.A.; Zaki, D.A.; Hamzat, T.K. Expectations of Individuals with Neurological Conditions from Rehabilitation: A Mixed-Method Study of Needs. S. Afr. J. Physiother. 2021 , 77 , 1498. [ Google Scholar ] [ CrossRef ]
• Banville, D.; Desrosiers, P.; Genet-Volet, Y. Translating Questionnaires and Inventories Using a Cross-Cultural Translation Technique. J. Teach. Phys. Educ. 2000 , 19 , 374–387. [ Google Scholar ] [ CrossRef ]
• Spilker, J.; Kongable, G.; Barch, C.; Braimah, J.; Bratina, P.; Daley, S.; Donnarumma, R.; Rapp, K.; Sailor, S. Using the NIH Stroke Scale to Assess Stroke Patients. J. Neurosci. Nurs. 1997 , 29 , 384–393. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Mahoney, F.I.; Barthel, D.W. Functional Evaluation: The Barthel Index: A Simple Index of Independence Useful in Scoring Improvement in the Rehabilitation of the Chronically Ill. Md. State Med. J. 1965 , 14 , 61–65. [ Google Scholar ]
• Sullivan, P.J.; LaForge-MacKenzie, K.; Marini, M. Confirmatory Factor Analysis of the Youth Experiences Survey for Sport (YES-S). Open J. Stat. 2015 , 5 , 421–429. [ Google Scholar ] [ CrossRef ]
• Tabachnick, B.; Fidell, L.S. Using Multivarite Statistics ; Pearson: Boston, MA, USA, 2007; Volume 3. [ Google Scholar ]
• Shimizu, S.; Kano, Y. Use of Non-Normality in Structural Equation Modeling: Application to Direction of Causation. J. Stat. Plan. Inference 2008 , 138 , 3483–3491. [ Google Scholar ] [ CrossRef ]
• Shi, D.; Lee, T.; Maydeu-Olivares, A. Understanding the Model Size Effect on SEM Fit Indices. Educ. Psychol. Meas. 2018 , 79 , 310–334. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Fornell, C.; Larcker, D.F. Evaluating Structural Equation Models with Unobservable Variables and Measurement Error. J. Market. Res. 1981 , 18 , 39–50. [ Google Scholar ] [ CrossRef ]
• Byrne, B.M. Structural Equation Modeling with AMOS: Basic Concepts, Applications, and Programming , 2nd ed.; Routledge: London, UK, 2010. [ Google Scholar ] [ CrossRef ]
• Schumacker, R.E.; Lomax, R.G. A Beginner’s Guide to Structural Equation Modeling ; Psychology Press: London, UK, 2004. [ Google Scholar ]
• Lam, C.; Yao, Q. Factor Modeling for High-Dimensional Time Series: Inference for the Number of Factors. Ann. Stat. 2012 , 40 , 694–726. [ Google Scholar ] [ CrossRef ]
• Clarke, D.J.; Forster, A. Improving Post-Stroke Recovery: The Role of the Multidisciplinary Health Care Team. J. Multidiscip. Healthc. 2015 , 8 , 433–442. [ Google Scholar ] [ CrossRef ]

Share and Cite

Paschalidou, K.; Tsitskari, E.; Tsiakiri, A.; Makri, E.; Vlotinou, P.; Vadikolias, K.; Aggelousis, N. Exploring Stroke Patients’ Needs: A Cultural Adaptation and Validation of the Modified Needs Assessment Questionnaire in a Greek Context. Healthcare 2024 , 12 , 1274. https://doi.org/10.3390/healthcare12131274

Paschalidou K, Tsitskari E, Tsiakiri A, Makri E, Vlotinou P, Vadikolias K, Aggelousis N. Exploring Stroke Patients’ Needs: A Cultural Adaptation and Validation of the Modified Needs Assessment Questionnaire in a Greek Context. Healthcare . 2024; 12(13):1274. https://doi.org/10.3390/healthcare12131274

Paschalidou, Katerina, Efi Tsitskari, Anna Tsiakiri, Evangelia Makri, Pinelopi Vlotinou, Konstantinos Vadikolias, and Nikolaos Aggelousis. 2024. "Exploring Stroke Patients’ Needs: A Cultural Adaptation and Validation of the Modified Needs Assessment Questionnaire in a Greek Context" Healthcare 12, no. 13: 1274. https://doi.org/10.3390/healthcare12131274

Article Metrics

Article access statistics, supplementary material.

ZIP-Document (ZIP, 227 KiB)

Further Information

Mdpi initiatives, follow mdpi.

Subscribe to receive issue release notifications and newsletters from MDPI journals

Academic Support for Nursing Students

No notifications.

Disclaimer: This case study has been written by a student and not our expert nursing writers. View professional sample case studys here.

View full disclaimer

Any opinions, findings, conclusions, or recommendations expressed in this case study are those of the author and do not necessarily reflect the views of NursingAnswers.net. This case study should not be treated as an authoritative source of information when forming medical opinions as information may be inaccurate or out-of-date.

PBL - Stroke Case Study

Info: 3486 words (14 pages) Nursing Case Study Published: 11th Feb 2020

Reference this

Tagged: stroke aphasia

If you need assistance with writing your nursing case study, our professional nursing case study writing service is here to help!

• Describe the blood supply of the brain.
• Explore the epidemiology of strokes.
• Explain the value of CT with and without contrast in this PBL scenario.
• Consider the treatment and prognosis of the patient.
• Amlodipine : A calcium channel blocker. It works by blocking calcium influx into smooth muscles cells of the wall
• Aphasia [2] : Difficulty in using language. It is categorised into four main types:
• Expressive aphasia – patients know what to say, but are having trouble saying what they mean.
• Receptive aphasia – patients are having difficulty making sense of the words or diagrams.
• Anomic aphasia – patients are facing problems recalling words, names or numbers. (“speaking in a
• Global aphasia – patients cannot speak, understand speech, read, or write. It is the combination of
• Pack year : unit for measuring the smoking history of a person as to be used in risk factor estimation.

• Equivocal plantar response : normal and consistent plantar reflex of both legs. Plantar reflex is a reflex elicited

• Haemorrhagic stroke : Aneurism of blood vessels in the brain that burst.
• Ischemic stroke : Blood vessels in the brain are either clog by local atherosclerosis or thromboembolism.
• Transient ischemic attack (TIA) : Same pathophysiology as ischemic stroke, but occurrence last less than 24 hours. Therefore, it is always a retrospective diagnosis.

• Explain the basic principle of CT with and without contrast in this PBL scenario.
• Thrombolytic (within golden 3-4.5 hours): Tissues plasminogen activator (tPA); Alteplase; Urokinase
• Intravenous fibrinolytic therapy
• Surgery: carotid endoterectomy/ angioplasty
• Ultrasound-enhanced thrombolysis
• Speech & language therapy helps people who have problems producing or understanding speech.
• Physiotherapy helps with relearning movement and co-ordination of muscles.
• Psychological care helps with common mental health problems such as depression.
• Occupational therapy helps with assessing patients’ home and improving their abilities to carry out daily activities such as dressing and eating.
• Adams HP Jr, et al. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25: 1901-1914.
• Brierley JB. Experimental hypoxic brain damage. Journal of Clinical Pathology 1977s3-11: 181-187.
• Bryan RN, et al. Diagnosis of acute cerebral infarction: Comparison of CT and MR imaging. AJNR Am J Neuroradiol 1991; 12: 611-620.
• Clarke DD, Sokoloff L. Regulation of Cerebral Metabolic Rate. Basic Neurochemistry: Molecular, Cellular and Medical Aspects , 6 th edition. Philadelphia: Lippincott-Raven; 1999.
• Lee JM, Grabb MC, Zipfel GJ, Choi DW. Brain tissue responses to ischemia. J Clin Invest . 2000;106(6):723-731.
• MedlinePlus. Aphasia . Available at: http://www.nlm.nih.gov/medlineplus/aphasia.html . [Accessed 24 th March 2015].
• Michael-Titus A, Revest P, Shortland P. STROKE AND HEAD INJURY. The Nervous System , 2 nd edition: Elsevier Limited; 2010. pp. 200-209.
• NICE. Alteplase for treating acute ischaemic stroke (review of technology appraisal guidance 122) . Available at: http://www. nice.org.uk/guidance/ta264/chapter/1-guidance. [Accessed 11 April 2015].
• Rull G. Thrombolytic Treatment of Acute Ischaemic Stroke . Available at http://www.patient.co.uk/doctor/thrombolytic-treatment-of-acute-ischaemic-stroke . [Accessed 11 April 2015].
• Stoke Association. State of the Nation Stroke Statistics-January 2015 . Available at: http://www.stroke.org.uk/resource-sheet/state-nation-stroke-statistics . [Accessed 11 April 2015].
• Townsend N, et al. Coronary heart disease statistics 2012 edition . British Heart Foundation: London
• Xavier AR, et al. Neuroimaging of Stroke: A Review. South Med J . 2003;96(4). Available at: http://www.medscape.com/viewarticle/452843_2 . [Accessed 11 April 2015]

Cite This Work

To export a reference to this article please select a referencing stye below:

Related Services

• Case Study Service

• Nursing Essay Writing Service

• Reflective Writing Service

Related Content

Content relating to: "aphasia"

Aphasia has many etiologies, such as stroke, infection, brain abscess, brain tumour, nutritional deficiencies, or toxemia. However, the most common cause of aphasia in adults is cerebrovascular accident, which includes several types and classifications for aphasia.

Related Articles

Treatment Methods for Anomia in Aphasia

According to Brookshire (2015), aphasia has many etiologies, such as stroke, infection, brain abscess, brain tumor, nutritional deficiencies, or toxemia. However, the most common cause of aphasia...

Written by: Yung Bing Yong Introduction The brain is the primary organ of the centre nervous system that controls our body and houses our mind. It is metabolically active and dependent on a continuou...

Broca’s Aphasia and Treatment Options for Word Finding Difficulties

 A common condition that is an acquired language/communication disorder is known to be Aphasia. This disorder is usually caused from head trauma, brain tumors, stroke, or other neurogenic co...

DMCA / Removal Request

If you are the original writer of this case study and no longer wish to have your work published on the NursingAnswers.net website then please:

Our academic writing and marking services can help you!

• Marking Service
• Samples of our Work
• Full Service Portfolio

Related Lectures

Study for free with our range of nursing lectures!

• Drug Classification
• Emergency Care
• Health Observation
• Palliative Care
• Professional Values

Write for Us

Do you have a 2:1 degree or higher in nursing or healthcare?

Study Resources

Free resources to assist you with your nursing studies!

• APA Citation Tool
• Example Nursing Essays
• Example Nursing Assignments
• Example Nursing Case Studies
• Reflective Nursing Essays
• Nursing Literature Reviews
• Free Resources
• Reflective Model Guides
• Nursing and Healthcare Pay 2021

Ohio State nav bar

The Ohio State University

• BuckeyeLink
• Find People
• Search Ohio State

Review Question Answers

What acronym is used to to help identify strokes?

Answer: F.A.S.T – Facial droop, arm drop, speech problems, time. This acronym is universally used to easily teach people how to recognize a stroke. The other acronyms are not used to help people identify strokes.

What are some risk factors for having a stroke? Select all that apply.

Answer: Uncontrolled hypertension, and smoking. Uncontrolled hypertension can damage blood vessels and cause vasoconstriction making it more likely for a clot to form and obstruct the blood flow to the brain. Smoking can also damage blood vessels and cause vasoconstriction, smoking can increase the risk of stroke by up to 50%. Physical activity decreases, not increases, the risk of stroke. Drinking 8 glasses of water is healthy for the body and does not cause an increased risk of strokes.

What is the difference between a TIA and a stroke?

Answer: While both are caused by a lack of blood flow to one or more areas of the brain and they share many of the same clinical manifestations, the symptoms of a TIA resolve in an hour or less.

What is the postictal phase?

Answer: The postictal phase is the period of time immediately following an epileptic seizure and may last from a few minutes to hours. Clinical manifestations often mimic a stroke. Patient history and testing is needed to differentiate the two.

What is the difference between a thrombotic stroke and an embolic stroke?

Answer: A thrombotic stroke is due to thrombi formed in the intracranial vessels or vessels that feed the brain. An embolic stroke happens when fragments break from a thrombus that is formed outside of the brain.

What are two types of hemorrhages that can occur in a hemorrhagic stroke?

Answer: Subarachnoid & intracerebral. Subarachnoid is a bleed that occurs between the brain and the dura while an intracerebral bleed occurs actually in the brain parenchyma. The other answers are classified as ischemic strokes.